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Abstract  
 
Electrophysiology is the best discipline to functionally characterise neuronal behaviour, as 
such, electrophysiology plays a key role in neurological disease modelling and therapy. 
Totipotent stem cells have the limitless possibility to differentiate into any type of cell within 
the human body and therefore used frequently in disease modelling and therapy. This thesis 
aims to electrophysiologically assess the use of stem cells in disease modelling and therapy 
across two diseases; the infantile epilepsy disorder - cyclin dependant kinase like 5 (CDKL5) 
deficiency, and the fatal neurodegenerative condition - Huntington’s Disease, respectively. 
This thesis shows that a patient induced pluripotent stem cell derived cortical neuronal model 
of CDKL5-deficiency recreates the epilepsy seen in patients, providing a valid disease model. 
Furthermore, these neurons can be cultured on a high-throughput multi-electrode array for 
the rapid testing of novel therapeutic compounds. In the disease therapy side of the project, 
stem cell grafts fail to functionally integrate synaptically into a rat model of Huntington’s 
Disease (HD), however restore synaptic function in the lesioned striatum. These data suggest 
that the stem cell graft may provide therapeutic benefits, just not electrophysiologically. 
Taken together, these observations suggest that stem cells can reproduce the defining clincal 
charactersistics, epilepsy, lacking from other model systems in an infantile epilepsy model 
and induce acute therapeutic benefits in a rodent model of HD. 
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Chapter 1 - General Introduction 
 
1.1 Stem Cells: Origins, applications and issues  
 
1.1.1 Human embryonic stem cells (hESCs) 
Stem cells have the unique ability to differentiate into the many other types of mature cells 
within the body, and can broadly be classified as either embryonic or adult. Embryonic stem 
cells are pluripotent, meaning that they can differentiate into cells derived from the three 
primary germ layers: endoderm; mesoderm, and; ectoderm. Adult stem cells tend to reside 
in the tissue with which they are associated, and are more restricted in their differentiation 
potential (Boyle, 2008). Following formation of a zygote, the next steps in embryogenesis are 
the merula, followed by the blastocyst. The blastocyst is composed of the external 
trophectoderm and inner cell mass (ICM). It is from this ICM that embryonic stem cells are 
taken. Originally isolated from the mouse embryonic ICM in 1981 (Evans and Kaufman, 1981), 
it wasn’t until 1998 that the first hESC was generated (Thomson et al., 1998).  
Within the hESC is a complex transcriptional regulatory circuit that impairs differentiation and 
maintains pluripotency; this regulatory pathway intimately involves SOX2, OCT4 and NANOG 
(Boyer et al., 2005). These transcriptional regulators simultaneously inhibit transcription of 
certain genes such NEUROG1, essential for neurogenesis (Gao et al., 2009), and HAND1, 
essential for mesoderm development (Barnes et al., 2010 p.1), whilst promoting the 
expression of genes such as MYST3, SET and SMARCAD1; genes involved in histone 
acetylation, methylation and chromatin remodelling, respectively. 
The milestone generation of hESCs in 1998 provided the first reliable source of stem cells for 
disease modelling and drug discovery and are still employed today (Marolt et al., 2012). The 
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first successful use of hESCs for disease therapy was 14 years later when hESC-derived retinal 
pigment epithelium were transplanted into the eye of a patient with Sargardt’s macular 
dystrophy (Schwartz et al., 2012). However, clinical use of hESCs remains limited, largely due 
to the fears surrounding hESC graft-derived tumour formation as a result of the fast 
proliferation and self-renewal properties of hESCs (Hentze et al., 2009). The other large 
practical concern surrounding the use of hESC derived grafts in disease therapy is associated 
with immune rejection and the need for patients to be on immune rejection therapy before, 
during and a long time after the surgery. Furthermore, the fact that hESCs are derived from 
human embryos is a source of huge ethical concern amongst certain sections of society.  
 
1.1.2 Induced pluripotent stem cells (iPSCs). 
A potential alternative to hESCs, potentially bypassing the ethical issues surrounding their 
human embryonic source, was presented by Takahashi et al., with the advent of iPSCs. In 2006 
Takahashi & Yamanaka first demonstrated the generation of embryonic-like features by 
reprogramming murine fibroblast cells using retroviral transfection of genes associated with 
pluripotency OCT3/4, Sox2, Klf4 and c-Myc (Takahashi and Yamanaka, 2006). This 
revolutionary step was then refined to generate human iPSC (h-iPSC) from human fibroblasts 
(Takahashi et al., 2007). 
The advent of h-iPSCs allowed the generation of patient- and disease-specific models on 
which to test novel therapeutics.  Furthermore, the ability to generate h-iPSCs could, in 
principle, allow for patient-specific grafts, autografts, that might bypass the practical 
problems associated with immune rejection. However, there are still issues surrounding the 
use of h-iPSCs which may limit their clinical applications, including: i) iPSCs appear to have a 
more ‘closed’ chromatin structure compared to their hESC counterpart and questions remain 
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about the ‘completeness’ of the reprogramming and whether any somatic memory persists, 
and; ii) induction of pluripotency as a result of transfection of proto-oncogenes (LING et al., 
2012; Wuebben and Rizzino, 2017; Zhao et al., 2018),. may lead to teratoma formation in 
grafts. 
 
1.1.3 Ganglionic eminence cells 
During neurogenesis the ICM of the blastocyst forms two layers collectively termed the 
bilaminar embryonic disc. The external layer of this disc, the epiblast, gives rise to the three 
primary germ layers; the endoderm, mesoderm and ectoderm. It is the ectoderm that forms 
the neural plate and subsequently the neural tube between days 20 and 29 post fertilisation 
in humans. The anterior part of this neural tube then develops into the prosencephalon, 
giving rise to the telencephalon and diencephalon. The ventral telencephalon then matures 
into the medial, lateral and caudal ganglionic eminences (MGE, LGE and CGE) and the anterior 
entopeduncular area. The ganglionic eminence, a transitory brain structure, facilitates 
tangential cell migration, eventually forming the basal ganglia which are made up of the 
striatum and globus pallidus (Bear et al., 2001). 
Harvesting of the MGE, LGE and CGE, collectively termed the whole ganglionic eminence 
(WGE) from medically terminated human foetal tissue generates human WGE (hWGE) cells. 
Rat WGE (rWGE) are neurons harvesting from the ganglionic eminence of foetal rat tissue in 
the same way. These embryonic cells are much further along their respective differentiation 
timelines and, as such, can only differentiate into a very limited subset of neurons making 
them neural progenitor cells, rather than stem cells. The use of human WGE (hWGE) is 
associated with very significant ethical concerns since the cells are harvested from relatively 
late gestation human foetuses (between 8 and 14 weeks post-conception). However, these 
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cells are not as commonly associated with issues surrounding teratoma formation making 
them an attractive source of cells for cell replacement therapy. 
 
1.1.4 Stem cell technology and neurological disease modelling and therapy 
Stem cells have proven invaluable in modelling neurological diseases and have led to the 
discovery of key pathogenic processes and testing of novel therapeutics. Due to the difficulty 
and enormous risk associated with harvesting brain tissue from living patients, development 
of an efficient and replenishable model is paramount. Animal models have commonly been 
used to study human neurological diseases. However, animal brains develop differently to 
human brains and as such animal models of neurological diseases may not fully recapitulate 
the disease progression in human tissue. The use of human ESC/iPSC has facilitated the 
modelling of many neurological disorders including, but not limited to, amyotrophic lateral 
sclerosis (Dimos et al., 2008; Boulting et al., 2011), Huntington’s disease (HD)(Park et al., 
2008), Parkinson’s disease (Soldner et al., 2009; Nguyen et al., 2011) and Rett’s syndrome 
(Marchetto et al., 2010; Cheung et al., 2011). 
Furthermore, stem cells have huge possibilities in neurological disease therapy. 
Neurodegenerative conditions are associated with severe cell loss and effective therapies 
would therefore require effective cell replacement. Stem cells provide a potential source of 
neurons for use in such cell replacement therapies. However, and as already discussed above, 
there are concerns surrounding the pluripotent nature of the stem cells used in potential graft 
tissue. The use of WGE cells may alleviate some of this concern due to their limited potency. 
Indeed, grafting of hWGE cells into human HD patients has had some early promising results 
(Gaura et al., 2004; Reuter et al., 2008). Whilst limited potency is a vital characteristic, stem 
  5 
cell derived neurons used in grafts also need to accurately depict perhaps the most defining 
feature of neurons, their electrophysiological properties. 
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1.2 Electrophysiology: Basic principles and applications  
 
 
1.2.1 Bioelectricity and electrophysiology 
Neurons fall into a subcategory of cells within the body which are excitable. The term 
excitable refers to the ability of the cells to be electrically active and to generate action 
potentials. Neurons are not alone in this category, as muscle cells (smooth, cardiac and 
skeletal) and a small number of endocrine cells (pancreatic b cells) are also classed as 
excitable. The study of electrically excitable cells and their inherent bioelectrical properties is 
termed electrophysiology. 
Neurons, like other cells, have a membrane made of a stable phospholipid bilayer, with a 
hydrophobic interior and hydrophilic exterior, separating the extracellular solution from the 
intracellular cytosol. The polar nature of the phospholipid bilayer renders it impermeable to 
large and charged particles. Inserted into this membrane are protein structures known as ion 
channels, selectively permeable to charged ions, facilitating the flow of ions across the 
phospholipid bilayer. Importantly these ion channels are often gated, whereby they only 
facilitate the passive diffusion of ions across the membrane when certain parameters are met. 
Another type of protein commonly found in the cell membrane are ion pumps, that facilitate 
the active movement of ion channels against the concentration gradient through the 
consumption of adenosine triphosphate (ATP). It is indeed this transport of charged ions that 
facilitate the electrical activity of neurons.  
In order to understand the key concepts of electrophysiology a sound understanding of 
certain principles for physics is vital. Charge (Q) is measured in coulombs (C) and the rate of 
movement of charge is termed current (I), measured in C.s-1, or amperes (A). According to the 
convention established by Benjamin Franklin, positive current flows in the same direction as 
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the movement of positive charge. For example, placing positive (anode) and negative 
(cathode) electrodes in a solution containing cations (positively charged ions) and anions 
(negatively charged ions) would induce the moment of cations toward the cathode and the 
anions towards the anode, as opposite charges attract. It is therefore said that current flows 
from positive to negative, anode to cathode. Conductance of the solution and the potential 
difference between the electrodes determines the size of the current, i.e., how fast ions 
move.  
Potential difference, measured in volts (V) and otherwise termed voltage, is defined as the 
amount of work (measured in Joules, J) required to move a single unit of charge between two 
points. 1 J is required to move 1 C across 1 V difference. Conductance, measured in siemens 
(S), is considered to be the ease of flow of current between two points. The conductance 
between two electrodes in the earlier example could be increased by moving the electrodes 
closer together or by increasing the concentration of salt in solution. Decreasing the 
conductance could be achieved by increasing the solutions viscosity, distance between the 
electrodes or simply by placing an impermeable barrier between the two electrodes. 
Essentially, ion channels are conductors which facilitate the movement of ions across an 
otherwise impermeable membrane, the cell’s own phospholipid bilayer. The sum of the all 
conductors in parallel equal the total conductance of the membrane representing the number 
of open ion channels and the ease of passage through them. Conductance in simple 
conductors is defined by Ohm’s Law (Ohm, 1827):  
I = gE 
where I (current) is equal to the product of g (conductance) and E (voltage difference) across 
the conductor. Ohm’s Law is also seen represented using resistance (R), the reciprocal of 
conductance, measured in in ohms (W):  
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E = IR 
Ohm’s Law is pivotal in understanding the movement of ions across cell membranes.  
All that is required to generate a potential difference is the separation of charge via a 
capacitor. Capacitance (c), measured in farads (f), is the amount of charge (Q) transferred 
between two conductors to generate a defined potential. This can be written as: 
𝑐	 = 	𝑄𝐸 
where c refers to capacitance. When + 1 C of charge is on one side of the capacitor and – 1 C 
charge is on another side of the capacitor, a 1 f capacitor between the two will be charged 1 
V.  
As the thin neuronal cell membrane separates two conducting solutions from each other, the 
extracellular solution and the neuronal cytosol, the cell membrane can be seen to act as a 
capacitor.  Following on from this basic understanding of electrical concepts and seminal work 
in the giant squid axon, Hodgkin and Huxley proposed the Hodgkin-Huxley model cell (Bean, 
2007) (simplified in Figure 1.1) to describe the electrical properties of excitable cells, for which 
they won the 1963 Nobel Prize for Medicine or Physiology (Hodgkin et al., 1963). When 
considering the ion channels as rudimentary conductors allowing ions to pass through them 
there is a resistance associated with them, that is the resistance through an ionic pore. It is 
for this reason ion channels are represented as resistors in the model cell.  
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1.2.2 Equilibrium and membrane potentials 
The resting membrane potential (Vm) of the neuron is the potential difference across the 
membrane at a given time. Typically, this value is at -65 mV in neurons in the central nervous 
system (CNS), which is to say the inside of the membrane is 65 mV more negative than the 
outside. For a negative Vm to arise the inside of the cell needs to be more negatively, or indeed 
less positively, charged relative to the outside of the cell. In neurons, this occurs through a 
balance between equilibrium potentials controlled by relative permeabilities, as described 
below. 
For simplicity, the following four ions will be used to demonstrate the ions critical to neuronal 
function; Na+, K+, Ca2+, Cl-. In a situation where a solution of the four previously mentioned 
Figure 1.1: Basic components of the Hodgkin-Huxley model cell 
The lipid bilayer is represented as a capacitor (Cm). Non-linear and linear resistors represent 
voltage gated channels (gn) and leak channels (gL) respectively, and are associated with the 
electrochemical gradient driving the flow of ions; shown as batteries (En & EL). Ion pumps 
are shown here as current sources (IP) 
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ions is separated, by an impermeable barrier, from a 25 times diluted sample of the same 
solution there would be no net movement. As such the Vm would equal 0 mV as the ratio of 
each ion to each other on either side of the membrane would equal 1. Inserting a channel 
selective to a single ion, K+, would facilitate passive diffusion down the concentration gradient 
from intracellular to extracellular solution until equilibrium is met. Once in this state, the Vm 
at which the concentration of the ion is in equilibrium is known as the equilibrium potential 
(Eion). If the extracellular and intracellular concentrations of the ion are known, then the Eion 
can be calculated using the Nernst Equation:  
𝐸&'( = 2.303𝑅𝑇𝑍𝐹 𝑙𝑜𝑔10 [𝑖𝑜𝑛]'[𝑖𝑜𝑛]&  
Which describes the relationship between the Eion, the gas constant (R; 8.314 J K-1 mol-1), the 
absolute temperature (T), the valency of the ion (z), the Faraday Constant (F; 9.654 x 104 C / 
mol) and the concentrations of the ions extracellularly ( [ion]o ) and intracellularly ( [ion]I ). 
Using this equation for the hypothetical situation described previously in which two solutions, 
the extracellular being twenty-five fold more diluted than the intracellular, are separated by 
an impermeable barrier only allowing K+ diffusion at biological temperature (37 oC) the 
equation would look as follows: 
𝐸9 = 2.303𝑅𝑇𝑍𝐹 𝑙𝑜𝑔10 [𝐾;]'[𝐾;]& = 61.54	𝑚𝑉	𝑙𝑜𝑔10 125 = 	−86.029	𝑚𝑉	 
As shown above, the Eion for K+ is roughly -86 mV in this particular hypothetical situation. 
However, in neurons, the concentration gradient for each of the composite ions is not simply 
twenty-five fold. The following table describes the internal and external ion concentrations 
for the four most “important” biologically active ions, adapted from Lodish et al. (Lodish et 
al., 2000), Bear et al. (Bear et al., 2001), and Hille (Hille, 1984): 
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Ion Extracellular 
Concentration (mM) 
Intracellular 
Concentration (mM) 
Equilibrium 
Potential (mV) 
Na+ + 146.667 + 13 + 64.764 
K+ + 4.334 + 131.334 - 91.171 
Ca2+ + 1.5 < + 0.0001 + 128.498 
Cl- + 129.667 + 7.067 - 77.761 
 
Averaging these equilibrium potentials generates a much higher value than the Vm seen in 
mammalian neurons of roughly -65 mV. Several factors contribute to this including relative 
permeabilities and ion pumps maintaining concentration gradients.  
Maintenance of concentration gradients is due in part to the relative permeabilities, but also 
heavily due to ion pumps like the sodium-potassium pump. The sodium-potassium pump, the 
discovery of which won Jens Skou the 1997 Nobel Prize for Chemistry (Boyer et al., 1997) 
breaks down adenosine triphosphate (ATP) in the presence on intracellular Na+ exporting it 
out across the membrane in exchange for extracellular K+. Maintenance of these 
concentration gradients is vital for function of all living cells. 
Ion channel permeabilities (P) are usually noted as relative to PK due to it having a much larger 
permeability than PNa and PCl . Typically, a neuron at rest is suggested to have permeability 
values as follows; PK : PNa : PCl = 1 : 0.05 : 0.45. Whilst Ca2+ invariably plays a role in neuronal 
bioelectricity, it’s impact on membrane potential is comparably low due to low intracellular 
Table 1.1: Extracellular and intracellular ionic concentration of mammalian neurons 
The concentrations of Na+, K+, Ca2+, Cl- intracellularly and extracellularly with respect to 
mammalian neurons on the CNS. Values taken from Lodish et al., Bear et al., and Hille and 
calculated using the Nernst Equation. All calculations performed at biological temperature 
(T = 37 oC or 310.15 K) 
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(1.25 mM) and extracellular (< 0.0001 mM) concentrations and a much smaller permeability 
(< 0.01% of PK)(Spangler, 1972). It is for these reasons that Ca2+ is not included in the Goldman-
Hodgkin-Katz equation which incorporates relative permeabilities to calculate the Vm as 
follows: 
𝑉D = 2.303𝑅𝑇𝐹 𝑙𝑜𝑔10E𝑃G[𝐾;]' +	𝑃IJ[𝑁𝑎;]' + 𝑃MN[𝐶𝑙P]&𝑃G[𝐾;]& +	𝑃IJ[𝑁𝑎;]& + 𝑃MN[𝐶𝑙P]'Q 
Inserting the extracellular and intracellular concentrations as calculated in Table 1 and 
relative permeability values (PK : PNa : PCl = 1 : 0.05 : 0.45), generates a theoretical resting 
membrane potential similar to that seen in neurons at rest, as follows: 
𝑉D = 61.54	𝑚𝑉	𝑙𝑜𝑔10 R 4.334 + 	7.334 + 3.18131.334 + 	0.65 + 58.35T = 	−68.177	𝑚𝑉 
 
1.2.3 Electrochemical communication via action potentials and synaptic transmission 
Electrochemical communication in mammalian neurons relies on manipulation of these 
membrane potentials and ion channels. Ion channels themselves can be gated by both ligands 
and/or membrane potential, whereby a ligand binding or the membrane potential changing 
induces a conformational change to facilitate the passage of ions through the pore. For 
example, in voltage gated Na+ channels three states of ‘activation’ exist: closed, open and, 
inactivated. Whilst in closed and inactivated, the channel remains impermeable to ions. 
Whilst Vm = ~ - 70 mV, voltage gated sodium channels are in their closed state where the 
activation gates block the pore extracellularly. Upon electrochemical stimulation, these 
activation gates undergo conformational change to facilitate the passage of ions through the 
pore, transitioning from closed to open state, i.e. activation. In the open state Na+ continues 
to pass through the pore depolarising the membrane, facilitating the activation of other 
nearby voltage gated sodium channels. Following depolarisation of the membrane the 
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inactivation gate then conformationally alters to render the pore impermeable to  Na+ and 
therefore in its inactivated state. The transition from inactivated to closed is time dependant.  
An action potential (neuronal) is a rapid reversal of potential across a membrane, largely 
dependent on Na+ and K+ channels, facilitating the passage of information from one point to 
another in the mammalian nervous system. A detailed exploration of all the facets of 
mammalian action potentials is outside the scope of this introduction to the basics of 
electrophysiology, but see Bean (Bean, 2007) for a detailed review. However, a brief 
explanation follows below. 
At rest, the membrane potential is maintained at roughly -65 mV via Na+/K+ pumps and 
leakage channels. The Na+/K+ pump generates a high intracellular concentration of K+  and 
low intracellular concentrations of Na+. As the neuronal membrane is considerably more 
permeable to K+, K+  diffuses out of the neuron at a much faster rate than Na+. The efflux of 
cations results in the interior of the cell being more negatively charged relative to the outside 
of the cell. Following a stimulus (ligand/mechanical/electrical) Na+ influx through open Na+ 
channels begins to depolarise the membrane. An action potential is only generated when the 
membrane continues to depolarise past a specific potential, termed threshold potential, of 
between -50 and -55 mV (Bostock et al., 1998) at which the voltage gates Na+ channels 
activate and become ‘open’. Once this threshold potential is passed voltage gated Na+  
channels open, increasing the Na+ conductance across the membrane and facilitating the 
rapid depolarisation associated with the rising phase of the action potential (Fig.1.2). During 
the rising phase, as the Na+ conductance is increased, Vm is brought closer to ENa and further 
from EK. Gradually, this increased voltage begins to inactivate voltage-gated Na+ channels, 
reducing the Na+  conductance relative to potassium conductance slowing the rate of increase 
of Vm. The increased Vm then fully inactivates voltage-gated Na+ channels, at the peak of the 
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overshoot, then causes the activation of voltage-gated potassium channels, increasing the 
potassium conductance and facilitating the falling phase of the action potential. During the 
falling phase Vm rapidly repolarises, towards EK. Voltage-gated potassium channels are 
comparatively slow to shut and are thus associated with afterhyperpolarisation of the 
membrane, which is negative of the resting Vm and closer to EK.  This period of 
hyperpolarisation is frequently termed the undershoot, afterhyperpolarisation or refractory 
period. During the refractory period, the voltage-gated Na+ channels are inactivated and thus 
the Na+ influx responsible for the rising phase of the action potential cannot occur, this is 
termed the absolute refractory period. Following removal of the N+ channel steady state 
inactivation there is still an increased K+ conductance due to the slow to inactivated voltage 
gated Na+ channels. This period is associated with a greatly increased threshold potential due 
to the increased Na+ conductance and is termed the relative refractory period. It is for these 
reasons that, under normal circumstances, action potentials cannot fire during the refractory 
period.  
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As the entire neuronal membrane is excitable, and the length of the neuronal axon is not 
separated into distinct compartments, action potentials are able to propagate along the 
length of the neuronal axon. As positively charged sodium ions rush into the axonal 
cytoplasm, this positive charge diffuses along the axon gradually depolarising the adjacent 
patch of membrane. Should this be sufficient to pass the threshold potential the voltage gated 
Na+  channels open in this patch and initiate another action potential, and thus the chain 
continues along the length of the axon (Fig.1.3). Cable theory is the mathematical set of 
models that aim to describe this phenomena in excitable cells. Hermann first described the 
Figure 1.2: Simplified action potential is largely controlled by sodium and potassium conductance 
The classical action potential shape is brought about largely by Na+ and K+ conductances. The influx 
of Na+ ions facilitates the sharp rising phase of the action potential, whilst the K+ ion efflux facilitates 
the repolarization and therefore falling phase of the action potential. Due to the relative latency of 
the closing of potassium channels, an undershoot (otherwise termed refractory period) is formed 
which is corrected through Na+/ K+ ATP-ase pumps. 
Abbreviations: Na: sodium, K: potassium, ATP: adenosine triphosphate 
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spread of action potentials using the theory for a “leaky telegraph cable” (Hermann, 
1905).Here the neuronal axons are considered as cylindrical compartments with capacitances 
and resistances combined in parallel. This conduction is termed orthodromic due to the patch 
of membrane behind the action potential being in a refractory state, driving the propagation 
along the axon in one direction. Usually action potentials initiate in the axonal hillock as the 
result of various stimuli, and then travel the length of the axon toward synapses and initiate 
synaptic transmission. 
 
Synaptic transmission facilitates rapid information transmission across large distances and 
multiple neurons. Most synaptic transmission within the mammalian nervous system is via 
chemical synapses; electrical synaptic transmission at specialised gap junctions made up of 
Figure 1.3: Action potential propagation along the neuronal membrane 
A: The inside of the cell is relatively more negative (orange) than the external solution. As sodium 
ions flood into the cell, the patch around this region is gradually depolarized, or made less 
negative/more positive (blue). This patch of more positive membrane, if more positive than the 
membrane’s threshold potential, will be sufficient to trigger an action potential in the adjacent 
patch.  
B: This movement continues along the axon of the neuron towards the synapse. 
Abbreviations: +ve: positive, -ve: negative 
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connexons is an exception to this rule (Hormuzdi et al., 2004). A chemical synapse is a 
specialised junction between two axons consisting of a presynaptic element, the synaptic cleft 
and the postsynaptic element. The presynaptic element contains large numbers of vesicles 
containing neurotransmitters such as Acetylcholine, Dopamine, Noradrenaline, Gamma-
aminobutyric acid (GABA), Glutamate and Glycine. Each vesicle has multiple vesicle Soluble 
N-ethylmaleimide-sensitive factor Attachment protein REceptors (v-SNAREs) which interact 
with target-SNAREs (t-SNAREs) on the internal surface of the presynaptic terminal membrane. 
Release of synaptic vesicles is largely mediated by Ca2+ influx through voltage-gated calcium 
channels that activate upon membrane depolarisation as a result of an action potential 
reaching the presynaptic terminal. This influx of Ca2+ facilitates the binding of v-SNAREs to t-
SNAREs through interaction with synaptotagmin to form a trans-SNARE complex. The 
formation of this trans-SNARE complex draws the membranes of the neurotransmitter vesicle 
and the presynaptic terminal so close that they fuse and release the neurotransmitters 
contained in the vesicle into the synaptic cleft via endocytosis. 
Postsynaptic neuronal membranes, possess cell-specific arrays of neurotransmitter 
receptors. For example, in the case of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
(AMPA) receptor (AMPAR)-mediated synaptic transmission, the presynaptic element would 
contain Glutamate and the postsynaptic element would possess AMPARs. AMPARs are 
transmembrane proteins consisting of four subunits (GluR1-4) that assemble into ionotropic 
receptors (Greger et al., 2017) that allow passage of Na+ and K+ with equal permeability upon 
Glutamate binding to AMPAR ligand binding domains. This increased conductance to both 
Na+ and K+ drives the Vm towards ENa (67.674 mV) and EK (-91.171 mV) equally, thus driving 
Vm towards 0 mV, depolarising the membrane which, in turn, activates voltage-gated sodium 
channels to generate action potentials on the postsynaptic neuron. This transient 
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depolarisation of the post-synaptic neuron as a result of presynaptic neurotransmitter release 
and is termed an excitatory post synaptic potential (EPSP). 
Of particular interest is GABAergic signalling, as medium spiny neurons (MSNs) are the 
predominant type of neuron found in the striatum and are thought to be GABAergic inhibitory 
neurons (Gonzales et al., 2013). The majority of neurotransmitters are either seen as 
excitatory or inhibitory, yet GABA can function as both. GABA binds to GABAA, a Cl- selective 
ligand gated ion channel. In immature neurons the Cl- levels are more concentrated 
intracellularly than extracellularly, whilst in mature neurons the opposite is true. This switch 
in Cl- concentrations is largely controlled by relative expression of Cl- transporters. In 
immature neurons the expression of the Na+/Cl- cotransporter (NCC) and Na+/K+/Cl- 
cotransporter (NKCC) is upregulated, resulting in a net influx of Cl-. In more mature neurons 
the K+/Cl- cotransporter (KCC) and Na+/HCO3-/Cl- exchanger (NDCBE) are upregulated 
resulting in a net efflux of Cl-. In immature neurons, with a higher intracellular concentrations 
of Cl-, GABA binding to GABAA opens the pore facilitating the passage of Cl- down the 
concentration gradient. This efflux of negatively charged Cl- causes the inside of the neuron 
to become less negative or depolarised. GABA is therefore excitatory in immature neurons. 
In mature neurons GABA binding to GABAA induces a net influx of Cl-, resulting in a 
hyperpolarisation of the membrane. Furthermore, GABA itself has been shown to drive the 
transition from excitatory to inhibitory via regulation of messenger ribonucleic acid (mRNA) 
levels of KCC (Ganguly et al., 2001). 
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1.2.4 Application of theoretical principles 
Recording these electrochemical signals has taken many forms and has progressed rapidly 
from relatively simple glass electrode, as used by Hodgkin and Huxley in the giant squid axon 
(Hodgkin, 1952), to complex in vivo multi-electrode arrays. Visualisation of any 
electrophysiological activity is a simple application of the theoretical principles outlined 
above. Multiple ‘patch’ techniques involving a glass micropipette exist and are broadly 
divided into whether the patch of membrane remains attached to the cell or whether it 
becomes excised.   
Recordings made whilst the electrode is attached to the cell can be further divided into ‘cell-
attached’, ‘whole cell’ and ‘perforated patch’. Cell-attached recordings involve a glass 
micropipette with a very fine tip diameter of between 1-3 µm. This micropipette is filled with 
a conducting solution, made to mimic the extracellular solution, and houses an electrode 
inside the micropipette capable of simultaneously stimulating and recording. The tip must be 
brought in close contact with the neuronal cell, close enough to form a ‘giga-seal’ where the 
resistance between the tip of the electrode and neuronal membrane is in the order of giga-
ohms (GW). Formation of the ‘giga-seal’ allows for isolation of the electrical activity seen 
across the patch of membrane under the tip from any electrical noise, as well as providing 
mechanical stability to the recording.  
During cell attached experiments, the experimenter leaves the membrane intact and 
therefore gains access to the conductance properties of a single or very few surface receptors 
and ion channels. This technique is relatively non-invasive as the membrane and intracellular 
processes are unaffected so it therefore more representative of the cell under physiological 
conditions. By the same measure leaving the membrane intact does not allow manipulation 
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of the internal solution and intracellular solutions. Cell-attached patch recordings are best 
employed when characterising single ion channel properties. 
 
Whole cell recordings follow a similar sealing protocol, however involve rupturing of the patch 
of membrane beneath the tip. Following formation of the ‘giga-seal’ a small patch can be 
ruptured allowing the micropipette tip and neuronal cell membrane to seal and facilitate 
mixing of the two solutions (Fig.1.4). Importantly, the solution in the pipette now is made to 
mimic the intracellular solution. By placing a reference electrode in the external solution the 
voltage can be measured internally (Vi ; by the electrode in the micropipette and subsequently 
Figure 1.4: Formation of the whole cell patch clamp configuration 
A: Positive pressure is applied through the tip of the micropipette which forms a ‘halo’ on the 
membrane (thick blue) of the neuron (yellow/blue) to be patched.  
B: When the micropipette, containing aCSF (red) and the electrode (black), is sufficiently close 
to the cell surface the positive pressure is released and the neuronal membrane is pulled close 
to the tip of the micropipette. If done correctly this will lead to the formation of a gigaseal.  
C: Negative pressure, usually applied in the form of suction, is applied to the micropipette which 
ruptures the patch of membrane beneath the tip of the micropipette facilitating mixing of the 
neuronal cytosol (yellow) and the aCSF (red). This will allow the cell to be dialysed, thus the 
large pipette volume compared to cell volume ensures that the inside of the cell becomes filled 
with the pipette solution over a period of several minutes. 
Abbreviations: aCSF: artificial cerebrospinal fluid 
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mixed solutions) and externally (Vo ; 0 mV by convention; by the reference electrode) allowing 
visualisation of Vm as follows: 𝑉D = 	𝑉& −	𝑉' 
If a patched neuron then fires an action potential, this can be visualised as the membrane 
potential would rapidly depolarise and repolarise giving rise to the classical shape of an action 
potential. Action potentials can be recorded spontaneously in a current clamp configuration 
where I = 0 or can be induced through utilising the electrode as both a stimulating and 
recording electrode in current step protocols. Here, in a current step protocol, sequentially 
more positive currents can be injected to depolarise the cell to induce action potentials. Patch 
Figure 1.5: Action potential properties revealed during whole cell patch-clamp 
experiments 
During whole cell patch clamp experiments, fluctuations in membrane potential can be 
observed allowing visualization of the classical action potential shape and dissection of it’s 
properties. The threshold potential is the minimum potential required for generation of a 
full action potential. The halfwidth is then taken as the action potential width at 50% maximal 
amplitude, which is calculated as the afterhyperpolarization value minus the peak amplitude. 
The maximum depolarization and repolarization rates are taken as the rate of change in 
voltage over seconds of the rising and falling phases respectively.  
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clamp is widely used to investigate synaptic function and can be applied in vitro to cultured 
neurons (Telezhkin et al., 2016), in vivo in anaesthetised animals (Tao et al., 2015) and ex vivo 
in tissue slices (Reidling et al., 2018). This technique grants unprecedented access to the 
membrane properties of an entire cell at rest, during an action potential (Fig.1.5) and 
throughout synaptic communication. For example, voltage clamp. During voltage-clamp 
experiments, the experimenter is ‘clamping’ Vm to a command potential (Vcomm) by 
continuously injecting a current to maintain this Vm. As the current being injected has to be 
equal to the current passing the membrane at any one time, it is therefore possible to record 
how the cell responds to changes in Vm. The drawbacks associated with whole cell patch 
clamp recordings include the invasive nature of whole cell recordings and subsequent impact 
on intracellular processes. Furthermore, whole cell patch clamp can struggle to capture 
network activity as the recordings are of single cells. 
The last of the patch recordings where the cell remains attached to the micropipette is 
‘perforated patch’. Perforated patch is very similar to cell-attached recordings whereby the 
membrane is not ruptured by the user, however is perforated by pore forming antibiotics 
such as amphotericin-B or nyastatin in the pipette. This technique grants the user access to 
the properties of the entire cell as in ‘whole-cell’ recordings, however is less invasive and 
disruptive of the intracellular solution and mechanisms. This technique is best employed 
when the whole cell properties are required however the impact of intracellular mechanisms 
is thought to have a larger impact on the question being answered. A drawback of this method 
is the higher access resistance caused the partial membrane left under the pipette which 
could potentially increase noise, furthermore continued exposure to the pore forming 
antibiotics could weaken the membrane to the point that the membrane ruptures. When this 
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occurs, the recording is then a whole-cell patch recording, where the internal solution is then 
contaminated by whichever pore forming antibiotic was used.  
The type of recordings made whereby the cell is no longer attached, and is therefore termed 
excised, can be divided into ‘inside-out’ and ‘outside-out’. Both recordings follow a very 
similar technique to whole-cell recordings, yet differ in how the membrane is ruptured. 
During inside-out recordings following gigaseal formation, the pipette is slowly withdrawn to 
break a patch of membrane loose from the cell being patched. A vesicle often forms here, 
which is often ‘popped’ by rapid transition through the air-liquid interface. The patch of 
membrane within the tip of the pipette remains intact, thereby exposing the internal surface 
of the cell to the extracellular solution. Doing so allows investigation of the effect of various 
intracellular ligands on the ion channels via perfusion through the bath solution. Outside-out 
recordings are very similar but involve rupturing the patch of membrane between the tip of 
the pipette to achieve a whole-cell configuration, then withdrawing the pipette slowly so that 
the membrane blebs forming a vesicle on the tip of the pipette. The internal surface of this 
vesicle being the external surface of the cell, and the external surface of the vesicle being the 
internal surface of the cell.  This technique affords the experimenter the unique ability to 
interrogate the properties of one, or a few, channels in isolation from the rest of the cell.  
Extracellular recordings are recordings made where no contact is made with the membrane 
of the cells being recorded and are therefore visualisation of a population of neurons in close 
proximity to the tip of the pipette. Extracellular field potential recordings performed on slices 
of brain tissue use a very similar micropipette and electrode to those used in whole cell patch 
clamp recordings. However, these electrodes are filled with a solution that mimics the 
extracellular solution, most commonly cerebrospinal fluid (CSF). The micropipette, when 
placed close enough, can record neuronal activity as a consequence of the mass movement 
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of charges during depolarisation across a population of neurons in close proximity; these are 
termed field-EPSPs (fEPSPs). It is also common during extracellular recordings to place a 
stimulating electrode nearby,  allowing  visualisation of evoked field potentials in order to 
examine connectivity between the stimulated region and the region being recorded. Figure 6 
compares the experimental set up of whole cell patch clamp experiments to extracellular field 
potential recordings. Due to extracellular field potentials recording information 
simultaneously from a population of neurons, the data gained does not provide the detail 
that whole cell patch clamp recordings can provide. The technique does require less skill than 
whole cell patch clamp recordings, however it is still comparatively user intensive and slow.  
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Multielectrode arrays (MEAs) aim to circumvent the time problem of the two previously 
described methods by allowing for long term, non-cell-invasive visualisation of neuronal 
activity from multiple populations of neurons simultaneously. Multiple types of ‘plates’ exist 
for in vitro culture neurons, ex vivo slices and more recently in vivo in live animals (Spira and 
Hai, 2013). A ‘plate’ here referring to a bed of electrodes of varying number and profile from 
the plate; slice MEA recordings required electrodes with a higher profile from the plate to 
record from the three-dimensional brain slice. These plates work very similarly to manual 
user-controlled experiments, recording electrodes subtracting differences in voltage 
Figure 1.6: Simplified experimental set ups during whole cell patch clamp and extracellular field 
potential recordings 
A: Whole cell patch clamp experiments require the tip of the micropipette to be sufficiently close 
the the neuronal membrane that a gigaseal can be created, the patch of membrane ruptured and 
mixing of neuronal solution and aCSF. The recordings electrode is then connected to measuring 
circuit which is simultaneously recording the potential difference in the bath solution and 
subtracting to the two to calculate the membrane potential. 
B: Extracellular field potential recordings are similar in respect to the recording electrode and 
reference electrode however the micropipette only needs to be in the vicinity of the neurons it 
intends to record the potential differences in the local area as a result of sodium and potassium 
conductances. A stimulating electrode is also common to record evoked field potentials.  
Abbreviations: aCSF: artificial cerebrospinal fluid 
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recorded from populations of neurons from a reference electrode, but are long-term in the 
sense that neurons can be cultured directly onto a plate containing ‘X’ amount of fixed 
position recording electrodes (Fig.1.7). This technique is so commonly used that commercially 
available kits are now available to streamline the whole process. Whilst vastly quicker, MEA 
experiments effectively ignore potential changes below an arbitrarily set threshold lending 
some bias and also do not provide the similar levels of detail to that recorded during whole 
cell patch clamp.  
  
Figure 1.7: Simplified MEA recording 
A: Overview of a single multi-electrode array well with twelve recording electrodes (orange) and 
one reference electrode (yellow).  
B: Exemplary image showing neurons cultured on an MEA well and four recording electrodes 
present (black). Overlaid in red are exemplary traces of the extracellular field potentials recorded 
at each electrode. Adapted from (https://www.multielectrodearrays.com/) 
Abbreviations: MEA: Multi-electrode arrays 
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1.3 Overall aims of the MPhil  
Neurological diseases have a devastating impact on those whom they inflict. The impact of 
defects within the CNS on patients can range from memory loss and behavioural changes to 
epileptic attacks and seizures. Rarely are neurological disorders not life limiting, and more 
often than not are fatal. As such, research into neurological diseases is vital. Due to the 
difficulty in obtaining human neural tissue, stem cells are an invaluable resource in not only 
modelling neurological disorders but also in disease therapy. In these neurological diseases, 
neuronal function is impaired in myriad ways. The best technique to interrogate the 
functional properties remains electrophysiology. The aims of this project are to assess 
electrophysiologically the use of stem cells in: i) disease modelling, using h-iPSCs derived from 
patients with the epileptic condition, CDKL5-deficiency, and; ii) cell replacement therapy, 
following engraftment  of h-ESCs into the striata of rats subjected to striatal lesions in order 
to model the fatal neurodegenerative condition, Huntington’s disease.  
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Chapter 2 – General Methodology 
 
2.1 Cell Culture 
 
Synaptojuice A/B Protocol. All cells, across both the Repair HD and CDKL5 projects, were 
exposed to a rapid maturation protocol prior to whole-cell patch-clamp recordings. This 
protocol was published by Telezhkin et al., (Telezhkin et al., 2016) and is commercially 
available as Synaptojuice. Cells were plated on poly-D-lysine (PDL) (Sigma) treated 22mm 
circular glass coverslips in Synaptojuice A, which contained; Advanced DMEM:F-12 (with 
Glutamax), 1 % penicillin/streptomycin, 2 % NeuroBrew21 (Miltenyi Biotec), 2 µM PD0332991 
(Selleckchem), 10 µM DAPT (Sigma), 0.6 mM CaCl2 (Sigma), 200 µM ascorbic acid (Sigma), 10 
ng/ml BDNF (Miltenyi Biotec), 1 µM LM22A4 (Tocris Bioscience), 10 µM forskolin (Tocris 
Bioscience), 3 µM CHIR 99021 (Tocris Bioscience), and 300 µM GABA (Tocris Bioscience). Cells 
were then maintained in Synaptojuice A for 7 DIV. At 7 DIV, the medium was switched to  
Synaptojuice B, which contained: 1:1 Advanced DMEM/F-12 (with Glutamax):Neurobasal A 
(Life Technologies), 1 % penicillin/streptomycin (Life Technologies), 2 % NeuroBrew21 with 
retinoic acid (Miltenyi Biotec), 2 µM PD0332991 (Selleckchem), 3 µM CHIR 99021 (Tocris 
Bioscience), 0.3 mM CaCl2 (Sigma-Aldrich), 200 µM ascorbic acid (Sigma-Aldrich), 10 ng/ml 
BDNF (Miltenyi Biotec), and 1 µM LM22A4 (Tocris Bioscience). The cells in the Repair HD arm 
of the project were maintained in Synaptojuice B for the following 14-21 DIV. LM22A4, CHIR 
99021 and BDNF are all direct or indirect inhibitors of GSK3b, and as GSK3b is thought to be 
central in CDKL5 pathogenesis it was hypothesized that the GSK3b modulators present in 
Synaptojuice B might be masking a disease phenotype. Therefore, half of the cells in the 
CDKL5 arm of the project were then switched to a Synaptojuice B media at DIV14, not 
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containing LM22A4, CHIR 99021 and BDNF hereby referred to as Reduced Synaptojuice, in an 
effort to reveal the disease phenotype. 
 
2.2 Slice preparation 
 
Lister hooded rats (Charles River) were anaesthetised with 4 µL of ketamine (Chanelle 
Pharmaceuticals Manufacturing Ltd., Ireland) and 2 µL of xylazine, (Bayer, UK) injected 
intraperitoneally in the lower abdomen, in order to preserve the intrastriatal field potentials. 
Reflexes were checked and, once absent, animals were culled via cervical dislocation by a 
colleague holding the appropriate Home Office Personal Licence and in accordance with 
Home Office regulations. Following removal of the head, the brain was removed, taking care 
not to damage the cortex or striatum. The brain was then immediately submerged in an ice-
cold sucrose cutting solution containing (in mM): 189 Sucrose (VWR Chemical, Leicestershire, 
UK), 10 D-Glucose (Fisher Scientific), 26 NaHCO3 (Sigma Aldrich), 5 MgSO4.7H2O (Fisher 
Scientific), 3 KCl (Fisher Scientific), 0.1 CaCl2 (Fisher Scientific) and 1.25 NaH2PO4 (Fisher 
Scientific) bubbled continuously with a 95 % O2 / 5 % CO2 gas mixture. From this step forward, 
the solution in which the brain/slices were submerged was subject to continuous bubbling 
with 95 % O2 / 5 % CO2 gas. 
Following rapid cooling in sucrose, the cerebellum was removed with a surgical scalpel and 
the remaining brain glued onto a stage of an Integraslice PS765 (Campden Instruments, UK) 
equipped with ceramic blades (Campden Instruments, UK). 400 µm thick coronal slices were 
cut, submerged in the ice-cold sucrose cutting solution. Slices were then transferred to a 
storage container submerged in artificial cerebrospinal fluid (aCSF) containing (in mM); 124 
NaCl (Fisher Scientific); 3 KCl (Sigma Aldrich); 24 NaHCO3 (Fisher Scientific); 1.25 NaH2PO4 
(Fisher Scientific); 1 MgSO4.7H2O (Fisher Scientific); 10 D-Glucose (Sigma Aldrich); 2 CaCl2 
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(Fisher Scientific). Slices were then left to recover at 37 oC for 45 minutes and then to stabilise 
for 60 minutes at room temperature prior to electrophysiological recording. 
 
2.3 Two Photon Bioluminescent Imaging 
 
Experiments were conducted in a commercially available PhotonIMAGERTM Optima (Biospace 
Lab, Nesles la Vallé, France) system interfaced to a personal computer running Photo 
Acquisition (Biospace Labs) and M3Vision (Biospace Labs) software. For green fluorescent 
protein (GFP) imaging, slices were imaged for 2 minutes in the aCSF. Slices were then exposed 
to a solution of D-Luciferin cell penetration formula containing in M; 0.001 D-Luciferin, 1 
Na3C6H5O7 (Sigma) brought to a final pH of 5.0 with acetic acid (Sigma). The slices were then 
imaged for 20 minutes to visualise bioluminescence.  
 
2.4 Electrophysiology 
 
Whole cell patch-clamp in culture. Whole cell patch-clamp recordings in culture were 
obtained using a Multiclamp 700A amplifier (Molecular Devices, Sunnyvale, CA, USA), 
digitised through a Digidata 1332A A/D convertor (Molecular Devices) and visualised on a 
connected personal computer running pClamp 9 (Molecular Devices) in a temperature 
controlled room set to 22 ± 0.5 °C. Signals were low-pass filtered at 2 or 5 kHz using and 8-
pole Bessel filter and were digitised at 10 kHz. . Recordings were made on neurons in 
extracellular solution containing the following (in mM): 135 NaCl (Fisher Scientific, 
Loughborough, UK); 5 KCl (Sigma-Aldrich, Poole, UK); 5 HEPES (Sigma-Aldrich), 10 D-Glucose 
(Fisher Scientific); 1.2 MgCl2 (Sigma-Aldrich); 1.25 CaCl2 (Sigma-Aldrich); pH adjusted to 7.4 
with NaOH. Cultured neurons were left to stabilise for at least 30 minutes prior to recordings.  
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Recording pipettes were pulled on Flaming Brown P-87 horizontal micropipette puller (Sutter 
Instrument Co, California, USA) from thin-walled glass capillaries (with internal filament, 1.0 
mm internal diameter, 6” long cut in two with diamond tip cutter; World Precision 
Instruments, Florida, USA). Pipette resistance was between 3 and 8 MW when initially 
immersed into the bath solution. A standard pipette solution was used in all experiments 
containing (in mM); 10 NaCl, 11 HEPES, 117 KCl, 2 MgCl2, 1 CaCl2 2 Na2-ATP (Sigma-Aldrich), 2 
Na-GTP (Sigma-Aldrich), 1.2 Na2-phosphocreatine (Sigma-Aldrich) and 11 EGTA (Fisher); pH 
was adjusted to 7.2 with KOH.  
Protocols used to interrogate membrane properties of cultured neurons were identical to 
those used by Telezhkin et al. (Telezhkin et al., 2016)  and are described as follows. Following 
GW seal creation and membrane rupture, resting membrane potential (mV) was determined 
in a ‘gap-free’ protocol in current clamp mode (I = 0) as was the presence of any spontaneous 
action potentials. Spontaneous activity was then defined as either; 1. quiet (no activity, no 
significant deviation from the mean), 2. attempted (attempted activity, significant deviation 
from the mean not resulting in full depolarisation), 3. spontaneous (full spontaneous activity 
resulting in full depolarisation, i.e. passing 0 mV). Current was injected to hyperpolarise the 
cell to approximately -70 mV before a current-step protocol injected current in increments of 
10 pA from -10 to +180 pA. Input resistance (MW) was then measured as the mean voltage 
difference between following -10 pA injection. The presence of any induced activity was 
determined and defined as; 1. quiet (no significant deviation from the mean), 2. attempted 
activity (significant deviation from the mean not crossing 0 mV), 3. single action potential 
(significant excursion from the mean resulting in depolarisation of the cell past 0 mV), 4. single 
action potential attempting train (single action potential followed one or more attempted 
action potentials), 5. train of action potentials (more than one successful action potential 
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crossing 0 mV in close proximity to one another).  
In the presence of induced action potentials, the first action potential following injection of 
current underwent spike analysis. The following parameters were then extracted; peak 
amplitude (mV), afterhyperpolarisation (mV), calculated spike amplitude (mV), depolarisation 
rate (mV/s), repolarisation rate (mV/s), half-width (ms), threshold potential (mV).  A detailed 
description of the process used to extract each parameter is defined in Chapter 3 of this 
thesis. 
Na+ and K+ currents were then recorded using a voltage-step protocol in the voltage clamp 
configuration using an initial holding potential of - 70 mV. The potential was then stepped 
from the holding potential to potentials ranging from - 120 mV to + 80 mV in 5 mV increments, 
with each sweep allowing visualisation of the Na+ activation current (pA). This was followed 
by stepping to 0 mV for a further 80 ms, to visualise the Na+ inactivation current (pA), before 
returning to the holding potential of - 70 mV. K+ currents (pA) were taken from the final 50 
ms prior to stepping to 0 mV. Cell capacitance (pF), allowing for calculation of current 
densities (pA/pF), and series resistance (MW) were measured and compensated prior to 
recording. 
Extracellular field potential recordings. Extracellular field potential recordings were 
performed on coronal slices submerged in aCSF maintained at 33 +/- 1 oC with a TC-324B 
Temperature Controller (Warner Instruments, Connecticut, USA) and SH-27B In-Line Solution 
Heater (Warner Instruments). The aCSF was bubbled continuously with 95 % O2 / 5 % CO2 
during recordings and recycled until drugs were added. Thin-walled glass capillaries (WPI) 
were pulled on a Flaming Brown P-87 horizontal micropipette puller (Sutter Instrument Co, 
California, USA) and used as recording electrodes. Tip resistances where 3.0 +/- 1 MW when 
initially submerged in solution. Signals from the recording electrodes were amplified through 
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a Multiclamp 700A (Molecular Devices) amplifier and digitised through a Digidata 1320A A/D 
convertor (Molecular Devices) before being visualised on a personal computer running 
pClamp 8 (Molecular Devices).  
Input/Output (I/O) curves were generated by stimulating through a CBARB100 concentric 
bipolar electrode (FHC Inc., Bowdoin, USA) connected to a DS2A-Mk.II constant voltage 
isolated stimulator (Digitimer, Welwyn Garden City, UK). I/O were generated first in order to 
establish the peak amplitude for each recording. A baseline stimulation protocol was used 
whereby the voltage of the stimulus was increased from 0 V to 80 V every 5 sweeps and the 
peak amplitude (mV) of the field potential recorded. The baseline stimulation protocol 
described was an episodic stimulation protocol, with a 1s long sweep every 20 seconds, 
stimulating at 55 ms for 200 µs at an intensity controlled by the digitimer.  After establishment 
of the peak amplitude, the slice was then recorded for 5 minutes at the maximal amplitude 
of the field potential on baseline stimulation protocol to determine whether the recording 
was stable. If the recording was stable and the amplitude of the field potential remained 
constant, a number of the following recordings were performed as required: a) paired-pulse 
facilitation recordings; b) theta burst stimulation recordings, and; c) the application of drugs 
during the 20s baseline stimulation protocol.  
The paired-pulse profiles were generated through four episodic stimulation protocols 
consisting of two stimuli of equal intensity 25 ms, 50 ms, 100 ms and 200 ms apart, 
respectively. The ratio between the paired-pulses were determined to reveal short term 
facilitation or depression of the field potentials. A theta burst stimulation protocol was 
adapted from Calabresi’s protocol (Calabresi et al., 1992) , in order to visualise synaptic 
plasticity. The above protocols were run intrastriatally on both hemispheres, contralaterally 
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and ipsilaterally to the graft/lesion. Following  this, graft-host, host-graft and intragraft 
recordings were also made. Electrode positions are shown in Fig 2.1. 
 
 
Multi-electrode array experiments. DIV16 neural progenitor cells (NPCs) were plated at a 
density of 150 x 103 cells/well onto PDL treated, 24-well multielectrode array (MEA) plates 
with 12 gold electrodes per well on epoxy (Multichannel Systems, Reutlingen, Germany). The 
plates were loaded onto a Multiwell-MEA Headstage (Multichannel Systems), for signal 
amplification, interfaced through a MCS-IFB Interface Board (Multichannel Systems). A 
baseline protocol was performed, absent of any stimulation, sampling at between 5 kHz to 
Figure 2.1. Recording and stimulating electrode positions on a coronal slice of the rat brain 
Coronal slices of the striatum (yellow) are shown above with recording (thin black) and 
stimulating (solid black) electrode positions shown for the various types of recording.; A. 
contralateral Intrastriatal; B. ipsilateral Intrastriatal; C. host-graft; D. intragraft and E. graft-host. 
Abbreviations: CG1: cingulate cortex area 1, CG2: cingulate cortex area 2, M2: secondary motor 
cortex, M1: primary motor cortex, S1FL: somatosensory 1 forelimb region, S1DZ: somatosensory 
1 dysgranular region, SIULp: primary somatosensory upper limb, S2: second somatosensory 
cortex, G1: granular insular cortex, D1: dysgranular insular cortex, AIP: agranular insular area, 
RV: right ventricle, CPu: caudate putamen (striatum). 
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measure spontaneous activity. Spike activity was determined as that activity above or below  
5 standard deviations of the mean of the noise. Data were then visualised through a 
connected personal computer running Multiwell Screen and Multi-Channel Suite 
programmes (Multichannel Systems). Timestamps were exported in .csv format and fed into 
my custom written MatLab scripts. 
 
2.5 Data Analysis and Graphical Representation 
 
MatLab. All data analyses and graphical representation was performed in MatLab using 
custom written scrips as described in the relevant chapter of this thesis. Data are shown 
throughout as mean values +SEM, and significance considered as p < 0.05. n refers to the 
number of recordings performed.  
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Chapter 3 – Development of novel MATLAB codes to facilitate the 
rapid, reliable and reproducible analysis of large complex 
electrophysiological data sets 
 
3.1 Introduction 
 
MATLAB is a multi-paradigm numerical computing environment developed by MathWorks 
(Massachusetts, USA), providing a powerful environment for data analysis and complex 
modelling widely used in academic research (Telezhkin et al., 2016; Penn et al., 2017; Ridler 
et al., 2018). Increasingly, the data generated by neurophysiologists require extensive data 
analysis before the data is then interpretable. This places taxing demands on time, whilst 
dramatically increasing the possibility of human error. Generating code to rapidly and reliably 
perform analysis of the large and complex datasets means that, not only is the experimental 
procedure documented and repeatable, the analysis procedure is also. Human error and bias 
are almost completely removed, and countless hours are saved. However, care must be taken 
to validate the code used to ensure that the analysis performed is accurate.  
 
3.2 Custom written code 
 
All code is made available digitally through MathWorks/GitHub following completion of this 
thesis. Included below are exerts of key portions of code. 
 
3.2.1 Automated whole cell patch clamp analysis 
Analysis of data generated from whole cell patch clamp analysis is a long process full of 
opportunities for errors to be made. It was therefore vital to develop a robust, reliable and 
documented approach to analyse the large complex data sets involved,  saving time in the 
process. To produce a MATLAB script for analysis, statistical testing and graphical 
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representation of whole cell patch clamp recordings multiple smaller scripts that dealt with 
the individual parameters, as described in Chapter 2, were developed and then packaged into 
a master script. The output of each of the smaller scripts was then put into a final structure 
that updated with each iteration of the master script, repeating with each set of recordings 
(one set = one cell) until a master structure was generated that contained all of the data 
extracted from all of the cells. 
Immediately following an experiment the data is saved as a ‘.abf’ file. It was therefore 
necessary to import the ‘.abf’ files into the MATLAB workspace. To do this ‘abfload.m’ was 
used, available from MATAL Central File Exchange (Hentschke, 2011). Shown in Figure 3.1, 
the resting membrane potential is extracted as the first ten seconds of recording in a gapfree 
protocol in current clamp mode (I = 0). Note the output, ‘Vm’, is assigned to the structure 
‘output’ and field ‘output.Vm’. 
 
Calculation of resting membrane potential does not require manipulation of the data past a 
mean calculation. To determine the input resistance of the cells it was necessary to measure 
the change in membrane potential during a current step protocol. As input resistance is 
measured in MW, the input resistance can be calculated from the voltage change and current 
Figure 3.1 Resting membrane potential MATLAB script 
Resting membrane potential (Vm) was extracted as the mean of the first ten seconds of a 
gapfree recording in current clamp mode (I = 0) as described in Chapter 2 of this thesis. 
Not shown, the ‘.abf’ file containing the gapfree recording is imported using ‘abfload.m’ 
as ‘GapFree’ is a separate function equal to ‘GapFree = abfload(‘filename.abf’)’.’ 1:20000’ 
is the first ten seconds due to the sample rate recordings were made at.  
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values as per Ohm’s Law (see Chapter 1). Figure 3.2 shows the code used to generate the 
input resistance from the data generated.  
 
 
Checkpoints were placed in certain scripts to allow the user to check the data is not corrupted 
in any way, by excessive noise or an articfact for example. The checkpoint requiring user input 
here is shown in lines 93 through 95. The function ‘getpts.m’, built in with the software, allows 
the user to identify a region to calculate the mean membrane potential from. Where possible 
this region is chosen as the last 10 ms of the current step prior to the membrane potential 
being clamped to 70 mV, for consistency between analysis. However, if an action potential 
Figure 3.2: Calculation of input resistance during a current step protocol utilising Ohm’s Law 
Input resistance (shown above as IR) is calculated from the voltage change following 
application of current during a current step protocol as per Ohm’s Law. The above script plots 
the first and second sweep of the current step protocol (line 89), then allows the user to 
determine a quiet region devoid of activity via the function ‘getpts.m’ (line 93-95). The mean 
value of these two regions is then subtracted from each-other to determine the voltage 
difference (line 96). As the current change is 10 pA (as defined in the protocol parameters), 
multiplication of the voltage difference in mV by -100 allows for calculation of the input 
resistance in MW, in accordance with Ohm’s Law. Not shown, the .abf file containing the 
current step recording was imported using ‘abfload.m’ as ‘CurrentStep’ (“CurrentStep = 
abfload(‘filename.abf’);”. 
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occurs during this period, the mean membrane potential will be considerably affected, thus 
‘getpts.m’ allows users to select a quiet region free from interference of action potentials. 
The ‘if’ statement in lines 84-86 allow for the rest of the master script to be performed in the 
absence of the current step recordings. Spike analysis was performed using a similar 
technique (Fig.3.3).  
Figure 3.3: Spike analysis script 
The above script plots the first 10ms of the sweep of interest, defined as ‘SweepNum’, 
specified in the electronic lab book kept during recordings (line 174). The function 
‘getpts.m’ was then used to select three points ‘x1’, ‘x2’ and ‘x3’ at three distinct points of 
the action potential; pre-threshold (x1), peak amplitude (x2) and post 
afterhyperpolarisation (x3) (lines 180-183). Peak amplitude (in mV) is taken as the 
maximum value between ‘x1’ and ‘x3’ (line 185). Afterhyperpolarisation (in mV) is taken 
as the minimum value between ‘x1’ and ‘x3’. (line 187). Calculated spike amplitude (in mV) 
is taken as the difference between peak amplitude and the afterhyperpolarisation (line 
189). The maximum depolarisation value (in V/s) is taken as the maximum gradient 
between ‘x1’ and ‘x2’ (line 191) and the maximum repolarisation rate (in V/s) is taken as 
the minimum gradient between ‘x2’ and ‘x3’ (line 193). Not shown, the ‘.abf’ file containing 
the current step recording was imported using abfload.m and saved as ‘CurrentStep’ 
where ‘CurrentStep = abfload(‘filename.abf’)’. 
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To determine the properties of the individual action potential, the function ‘getpts.m’ was 
utilised to allow the user to select the action potential of interest. Spike analysis, as described 
in Chapter 2 of this thesis, was performed on the first action potential following injection of 
current. 
In order to prepare visual representations of the experiments performed, a script was 
developed that plots exemplary recordings for inclusions in this thesis and future 
publications. As each sweep of the protocol passes, the trace is likely to shift in the window. 
It is therefore vital to adjust the traces so that they all start at the same level and are therefore 
comparable (Fig.3.4). 
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Figure 3.4: Plotting of exemplary recordings 
‘abfload.m’ imports the raw data in the ‘.abf’ format into the MATLAB work environment (line 
6), where the relevant channel is selected (line 7) and compressed into a vector with two rows 
(line 8). In lines 10-12 the relevant sweep is selected and then smoothened for plotting. The 
traces are then adjusted to the mean of the first 1000 data points (lines 14-16). The plot is then 
formatted to presentation standards in lines 18 to 31. 
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3.2.2 Automated extracellular field potential recording analysis 
In order to analyse extracellular field potential recordings, another semi-automated script 
was developed. The incorporation of a checkpoint requiring user action, as described earlier, 
was necessary to ensure the data was not interfered with by afferent fibre volleys or by large 
artefacts present in the recordings. It was also considerably easier to determine if a recording 
was actually a field potential (the presence of an afferent fibre volley and subsequent 
separate ‘smooth’ field potential) or simply an artefact (sharp and shorter) by eye rather than 
development of a script for this purpose. Furthermore, field potentials are highly variable 
responses (smoothness, amplitude, number of peaks, speed etc.) dependant on a large 
number of factors (age of animal, proximity of recording/stimulating electrode, site of 
recording in the brain etc.). Figure 3.5 shows a script that generates an input/output curve 
from the raw .abf file.   
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Figure 3.5: Input/Output Curve Script 
‘IO.m’ (shown here) takes the ‘.abf’ raw data file containing the experimental data for the 
input out protocol (lines 3-5), as described in Chapter 2, before adjusting all of the 
baselines to match (lines 7-9) and plotting all of the sweeps on top of one another (line 
12). Plotting all of the traces together ensures the region selected by ‘getpts.m’ (lines 15-
16) fully represented the field potentials change over time. The ‘for loop’ in lines 22-26 
extract the peak amplitude (in mV) at each stimulation intensity. Lines 29-39 then 
generates an array that contains the peak amplitude at each stimulation intensity for 
plotting in lines 41-45). 
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3.2.3 Automated multi-electrode array analysis 
As the MEAs used in this thesis contain 24 wells, each containing 12 electrodes sampling at 5 
kHz – one plate generates 1,440,000 data points per second. This enormous quantity of data 
requires a high powered environment capable of handling such quantities of data and 
performing complex analysis quickly. Therefore, a MATLAB script was developed. Much of the 
script developed for MEA analysis was developed in collaboration with Dr Jon Brown of the 
University of Exeter Medical School. As the question revolved around synchronicity as a 
marker of epilepsy, the emphasis of the script was placed on evaluating synchronicity using 
cross correlation matrices. In order to visualise the data over the course of the experiment, a 
raster plot was generated by using the ‘plotSpikeRaster.m’ function (Chiou, 2014). A modified 
version of ‘xcorr.m’, available as part of the Deep Learning Toolbox (Mathworks, 2018), was 
used to plot cross correlation matrices and develop a mean synchronicity index for each well. 
These were then packaged into a master script along with a script to produce a three 
dimensional plot of the spike count on each electrode in a well (Fig.3.6). 
 
  
Figure 3.6: Excerpt of MEA analysis script showing 3D Bar Plot code 
Shown here, ‘D3’ is a marker used to determine whether the master script should carry 
out the 3D Bar Plot segment of code. Lines 203-206 creates a 4x4 array with the number 
of spikes from each electrode. Note the corner positions on the array (1,1; 1,4; 4,1; and 
4,4;) are marked as zero as there was no electrode in these positions. Lines 208-220 format 
the plot as a subplot in the master figure (see Chapter 6), assign a colour bar and axis 
labels.  
Abbreviations: MEA: multi electrode array; 3D: three dimensional. 
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3.3 Validation of Code 
 
 
3.3.1 Validation of MATLAB scripts for analysis of whole cell patch clamp experiments 
To ensure that the code produced the same results as manual analysis, the developed 
MATLAB code was run and the manual analysis of the same dataset performed in parallel. 
The times taken for the MATLAB code to run, and for manual analysis to be performed, were 
also recorded. No significant differences were seen between manual analysis and MATLAB 
analysis (Fig.3.7), except in time taken to perform the analysis (11 cells analysis time in 
MATLAB: 00:04:34, and manually: 00:57:42). These data imply MATLAB analysis is a valid, 
rapid and reliable tool for the analysis of whole cell patch clamp datasets.  
Figure 3.7: Exemplar figures of MATLAB vs Manual analysis of the same dataset of whole 
cell patch clamp recordings 
Shown here are three parameters extracted from whole cell patch clamp recordings upon 
manual and automated analysis. The only difference seen (not shown) was the time taken 
to perform the analysis (11 cells analysis time in MATLAB: 00:04:34, and manually: 
00:57:42). 
A: Manual extraction of capacitance (in pF) (blue) plotted against MATLAB extracted 
values(orange), taken from the same dataset. 
B: Manual extraction of action potential halfwidth (in ms) (blue) plotted against MATLAB 
extracted values (orange), taken from the same dataset. 
C: Manual extraction of action potential amplitude (in mV) (blue) plotted against MATLAB 
extracted values (orange), taken from the same dataset. 
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3.3.2 Validation of MATLAB scripts for analysis of extracellular field potential recordings 
To validate the use of MATLAB scripts for the analysis of extracellular field potential 
recordings, the data generated from 18 input/output recording experiments were analysed 
manually and via MATLAB in parallel, then compared for differences. Shown in Figure 3.8 are 
two parameters extracted during the analysis of fEPSP recordings; half maximal stimulation 
intensity (Fig.3.8A) and fEPSP peak amplitude (Fig.3.8B). No significant difference in the result 
was observed upon testing via a student’s t-test, thus suggesting the use of semi-automated 
MATLAB analysis as a valid method of analysis. Furthermore, MATLAB analysis proved  
considerably faster (00:01:38) than manual analysis (00:18:06). 
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Figure 3.8: Exemplar figures of MATLAB vs Manual analysis of the same dataset of 
extracellular field potential recordings 
Shown are two parameters from extracellular field potential data analysis with MATLAB 
and performed manually. The only difference seen (not shown) was the time taken to 
perform the analysis (18 recordings analysis time in MATLAB: 00:01:38, and manually: 
00:18:06). 
A: Manual extraction of half maximal stimulation intensity (in V) (blue) plotted against 
MATLAB extracted half maximal stimulation intensity (orange), taken from the same 
dataset. 
B: Manual extraction of fEPSP peak amplitude (in mV) (blue) plotted against MATLAB 
extracted fEPSP peak amplitude (orange), taken from the same dataset. 
Abbreviations: fEPSP : field excitatory post synaptic potential 
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3.4 Discussion & Conclusion 
 
3.4.1 Accessibility of MatLab 
MATLAB has been shown here to be a valid tool for the use of large complex datasets. Not 
only is the analysis accurate, almost completely devoid of human error and bias, reproducible 
and documented – it is considerably faster. However, there are three major flaws associated 
with MATLAB: a) accessibility; b) confounding errors, and; c) code writing, which will be 
elaborated upon further here. MATLAB, and coding in general, is notoriously considered 
inaccessible to those who do not have coding experience. Despite MATLAB’s user-friendly 
graphics interface and extensive offline (and included) help section, many users are still 
intimidated by code and this can present a problem when trying to implement code in a 
project with multiple collaborators. The second flaw associated with MATLAB is the 
phenomena of confounding errors. MATLAB will generally not make a mistake unless it is told 
to make a mistake. MATLAB will rigidly follow the code laid out for it without mistake, therein 
lies the problem. Codes need to be written by humans and are, therefore, liable to human 
error. Should any errors written into the code not be noticed, and not cause a fatal error in 
the code, leading to it’s premature termination, then all of the analysis carried out will bear 
that error and data will be skewed. It is for this reason that all code should be extensively and 
regularly validated against manual analyses. As shown here, MATLAB was vastly quicker than 
manual analysis,  but the time taken did not account for the time taken to write the code 
itself. The time taken to write code is dependent on the complexity of the problem, the user’s 
understanding of the problem, and the user’s experience of code writing in MATLAB. For 
example, a novice coder, who is an expert electrophysiologist, will experience similar 
difficulties as an expert coder who has never seen electrophysiological datasets beforehand.  
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However, code writing is a non-linear learning process as the user’s vocabulary and 
experience multiply with each other.  
 
3.4.2 Semi-automation analysis allows for check points 
As described, MATLAB analysis can vastly increase the speed of the analysis and remove 
human error. However, any errors in the code will persist and can produce results that do not 
represent the actual biological phenomena being observed. It is for this reason that the 
analysis used in this thesis is termed ‘semi-automatic’ as checkpoints have been placed in the 
analysis protocol. These checkpoints require user action, although slowing down the analysis, 
allow the user to ensure that the data at each checkpoint is representative of the biological 
phenomena being observed. These checkpoints therefore ensure the validity of the data 
throughout. It was especially important to place checkpoints during the analysis of 
electrophysiological data as the traces can look profoundly different. Similarly, the MATLAB 
script could not detect whether the data was corrupted or impacted by a 
biological/experimental change such as a changing series resistance.  
 
3.4.3 Conclusion 
Taking into account the flaws described above, the MATLAB script was  validated as a highly 
efficient tool for the analysis of large complex datasets associated with electrophysiological 
experiments. Therefore, it’s use throughout this thesis for analysis, statistical testing and 
graphical representation was justified. 
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Chapter 4 – Establishment of an iPSC derived model of CDKL5-
deficiency for high-throughput screening of novel therapeutics 
 
 
4.1 Introduction 
 
 
Cyclin dependant kinase like 5 (CDKL5) deficiency is a severe, X-linked condition characterised 
by early onset epilepsy and mental retardation, closely resembling symptoms seen in Rett 
syndrome (Scala et al., 2005). Due to the condition’s X-linked nature, the majority of the 100 
reported cases have been seen in girls, with only 10% seen in boys. The most defining clinical 
manifestations include: a) normal prenatal history; b) irritability in the perinatal period; c) 
infantile spasms prior to 5 months; c) Rett like symptoms including, but not limited to: 
decelerated head growth; reduced voluntary hand movement; sleep disturbances, and; 
severe mental retardation (Bahi-Buisson and Bienvenu, 2011). These symptoms arise from 
disruptions in the serine threonine 9 gene (encoding the protein, CDKL5), such as missense, 
nonsense and frame-shift mutation which result in insufficient levels of the “healthy” 
protein;– as first described by Kalscheuer et al. in 2003 (Kalscheuer et al., 2003). Whilst much 
of the observed mental retardation is thought to arise from the severe and difficult-to-
manage early-onset epilepsy, increased markers of oxidative stress have been seen in 
patients’ peripheral lymphocytes (Pecorelli et al., 2011). This suggests that oxidative stress 
may also play a role in CDKL5-deficiency pathogenesis. 
The precise role of CDKL5 remains elusive despite multiple cell and animal models being 
developed. Thus far, the cell based models have implicated CDKL5 in neuronal morphogenesis 
(Chen et al., 2010a) through interactions with PSD-95 (Zhu et al., 2013), a post-synaptic 
scaffold protein. Furthermore, the phosphorylation and degradation of CDKL5 itself appears 
to be regulated by neuronal activity (Montanara et al., 2015). Two animal models have been 
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established (Wang et al., 2012; Amendola et al., 2014) which both exhibit characteristics 
similar to that seen in patients, and which implicate the AKT/GSK-3b pathways despite normal 
protein levels (Wang et al., 2012). Decreased phosphorylation of AKT and mTOR were 
observed, and were completely restored upon restoration of CDKL5 expression (Fuchs et al., 
2014). This observation was also true for survival of immature neurons, the apoptosis of 
which were greatly increased in the absence of CDKL5. Thus, CDKL5 appears to play key roles 
in both neurite outgrowth, neuronal survival and cell signalling. CDKL5 has also been 
implicated in histone modifications, specifically through phosphorylation of histone 
deacetylase 4 (HDAC4), resulting in decreased HDAC4 nuclear localisation and neuronal 
survival (Trazzi et al., 2016). Both were restored through GSK-3b and HDAC4 inhibition with 
SB216763 and LMK235, respectively (Fuchs et al., 2015; Trazzi et al., 2016). Intriguingly, 
hippocampal dependant memory tests performed in these animals following 
SB21673/LMK235 treatment resulted in significant improvements bringing the animals close 
to that of wild type mice (Fuchs et al., 2015; Trazzi et al., 2016).  
Despite promising studies, the precise role of CDKL5 remains elusive. Furthermore, the 
CDKL5-deficient mice (Wang et al., 2012; Amendola et al., 2014) did not display early onset 
epileptic phenotypes – the single most apparent characteristic seen in humans. This epilepsy 
is life-limiting and difficult to manage. Steroids are the recommended treatment for the initial 
infantile spasms (Pellock et al., 2010) and a variety of anti-epileptic drugs are added in 
combination dietary modification as the patients develop more severe seizures (Bahi-Buisson 
and Bienvenu, 2011). However, treatments are often not completely effective or patients 
with good early prognosis following treatment, patients often develop resistance to their 
prescribed treatment over time. Therefore, it is vital to generate a high throughput screening 
model of altered excitability. 
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4.2 Aims and rationale 
 
 
The precise neurophysiological impact of a mutation in CDKL5 is not known, and it is hoped 
that detailed characterisation of these properties will shed light on the causes of the life-
limiting epilepsy seen in CDKL5-deficiency patients. The use of patient-derived iPSC generated 
neurons should complement the previously conducted animal research whilst also hopefully 
recreating the epilepsy seen in patients. Should this epilepsy be visible in the iPSC derived 
cultures, a high throughput screening method would need to be established to facilitate 
testing of novel therapeutic compounds. Therefore, this project aims to characterise 
functionally CDKL5-deficiency patient-derived iPSCs as they differentiate into cortical neurons 
in order to develop a reliable platform for the rapid screening of future novel therapeutics.  
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4.3 Methods 
 
iPSCs were isolated from a female patient with the c.1375C>T (CAG>TAG) p.Q459X mutation. 
Due to the X-linked nature of CDKL5-deficiency, females carrying the mutation have one 
mutated copy and one wild type copy. Which copy is activated occurs at random in each cell.. 
Once the fibroblasts were converted to iPSCs by Dr David Millar at the Institute of Medical 
Genetics, Cardiff University, the cells were genotyped and isolated into colonies dependant 
on expression of either the mutant or wild-type CDKL5. Cells were then differentiated into 
neural progenitor cells and plated using the Synaptojuice protocol (Telezhkin et al., 2016), 
described in Chapter 2 of this thesis, on glass coverslips and multi-electrode arrays. The data 
shown here were generated over three plate-downs by Dr Christian Schnell (two plate-downs) 
and myself (one plate-down). Data generated by Dr Schnell are included only with his express 
permission. Data were then fed into my custom written MatLab script for analysis, statistical 
tests and graphical representation as described in Chapter 3 of this thesis. The MEA analysis 
script was written in collaboration with Dr Jonathon Brown of the University of Exeter Medical 
School and used within this project with his permission. 
Data are represented as mean values +SEM, where appropriate. One-way and two-way 
ANOVA’s with post-hoc Bonferroni corrected t-tests, Tukey’s test and students t-test, as 
appropriate.  
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4.4 Results 
 
4.4.1 iPSC derived neurons harbouring wild type and mutated CDKL5 mature at a similar rate 
using the Synaptojuice protocol  
To determine whether the c.1375C>T p.Q459X mutation affected the rate and extent of 
neuronal maturation, iPSC-derived neural progenitors were generated from an affected 
patient. The colonies were then isolated, plated on glass coverslips and matured using the 
Synaptojuice protocol (Telezhkin et al., 2016). Whole-cell patch-clamp experiments were then 
performed at DIV7, DIV14 and DIV21 to chart their maturation. Firstly, passive membrane 
properties were observed (Figure 4.1). Resting membrane potential was measured in current 
clamp mode (I = 0). 
A two way ANOVA was conducted to determine whether the differences observed were due 
to age (DIV) or group (mutant or wild-type). Here, the ANOVA p < 0.01. Mean resting 
membrane potential in the mutant CDKL5 line was significantly more negative at DIV21 (-
51.78 +/- 3.25 mV) than at DIV7 (-38.31 +/- 2.54 mV, p < 0.005, Figure 4.1A). Whilst no 
significant differences were seen in the wild type line, a similar trend was observed with DIV21 
being more negative than DIV7. Capacitance, a measure of cellular size and complexity, and 
input resistance, a marker of the number of open ion channels present, were then measured 
during a voltage-step protocol. The mutant line had a smaller mean capacitance (16.09 +/- 
0.96 pF) than the wild type line (19.38 +/- 0.14 pF) at DIV14 (p < 0.05, Figure 4.1B). No other 
significant differences were observed, although the capacitance does appear to increase over 
the time-course of the experiments. No significant differences in input resistance were 
observed between wild type and mutant neurons over 21 days post plating (Figure 4.1C). 
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Thus, as there are very few significant differences between the passive properties,  these data 
suggest that the c.1375C>T p.Q459X mutation in CDKL5 does not appear to have a large 
influence on the rate and extent of neuronal maturation as assessed by basic, passive 
membrane properties.   
 
 
Figure 4.1: Passive membrane properties of CDKL5 iPS derived cortical neurons mature over 
three weeks in Synaptojuice 
A-C: Bar charts plotting resting membrane potential (A), capacitance (B) and input resistance 
respectively of iPS derived neurons harboring both wild type CDKL5 (blue bars) and the 
c.1375C>T p.Q459X mutant CDKL5 (orange bars) matured over a course of 21 days post 
plating in line with the Synaptojuice protocol. Neurons underwent whole cell patch clamp 
experiments at DIV7, DIV14 and DIV21 to generate the data shown.  
Data shown here as mean +/- SEM. p* <0.05, p** <0.01 
Abbreviations: CDKL5: cyclin dependent kinase like five, WT: wild type, DIV: days in vitro, iPS: 
induced pluripotent stem cells 
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To determine whether the CDKL5 maturation affected active electrical properties, the ability 
of the neurons to generate spontaneous and induced activity was interrogated in whole-cell 
patch-clamp experiments. Spontaneous activity was observed in current-clamp mode (I = 0) 
and then classified as either quiet, attempting or spontaneous (as described in Chapter 2). 
Spontaneous activity was observed in both wild type (Figure 4.2A-C) and mutant (Figure 4.2D-
E) CDKL5 lines at all stages of maturation. The number of wild type neurons exhibiting 
spontaneous activity also increased from 7 % at DIV7, 38 % at DIV14, to 45 % at DIV21 (Figure 
4.2A-C). A similar trend was observed in the mutant CDKL5 neurons from 23 % of cells 
exhibiting spontaneous activity at DIV7, 67 % at DIV14 to 71% at DIV21 (Figure 4.2D-E). These 
data suggest that neurons with either variant of CDKL5 are able to generate spontaneous 
activity at their resting potentials and that this activity increases over time as the neurons 
mature. Neurons expressing the mutant CDKL5 appear to have a greater propensity for 
spontaneous activity at all stages of maturation. Inspection of the exemplar traces, such as 
those in Figure 2F, suggest that there are commonly more bursts of spontaneous activity in  
wild type than in mutant neurons (Figure 4.2C).   
The levels of electrical activity were observed during a current-step protocol (holding the Vm 
close to -70 mV, as described in Chapter 2) and then classified as either quiet, incomplete 
activation, single, single attempting train or train activity (also described in Chapter 2). 
Induced trains of action potentials were observed in both wild type (Figure 4.3A-C) and 
mutant (Figure 3.3D-E) lines at all stages of maturation. The number of wild type CDKL5 cells 
exhibiting trains of activity also increased from 23 % at DIV7, 29 % at DIV14, to 47 % at DIV21 
(Figure 3.3A-C). A similar trend was observed in the mutant CDKL5 from 7 % of cells exhibiting 
trains of activity at DIV7, 28 % at DIV14 to 47% at DIV21 (Figure 4.3D-E). These data suggest 
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that neurons with either variant of CDKL5 are able to generate trains of induced action 
potentials that increase over time as the cells mature. Taken together these data suggest that 
the presence of the c.1375C>T p.Q459X mutation in the CDKL5 protein does not significantly 
affect the ability of neurons to generate spontaneous or induced action potential generation, 
nor does it significantly impair the rate of maturation of these properties.  
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Figure 4.2: Spontaneous activity levels of CDKL5 iPS derived cortical neurons mature over three 
weeks in Synaptojuice 
Pie charts, accompanied by exemplary recordings, showing the levels of spontaneous activity 
measured from iPS derived neurons harboring the wild type CDKL5 and the c.1375C>T p.Q459X 
mutant CDKL5 during whole cell patch clamp experiments, during maturation in line with the 
Synaptojuice protocol. Experiments were performed at DIV7, DIV14 and DIV21 to chart the 
maturation of the cells.  The red segments in the pie charts represent quiet cells devoid of action 
potentials, the yellow represents incomplete activation of action potentials and the green 
represent spontaneous activity where action potentials result in complete depolarisation of the 
neurons crossing 0 mV.  
A-C: pie charts and exemplary recordings of wild type CDKL5 neurons at DIV7, DIV14 and DIV21 
respectively.  
D-F: pie charts and exemplary recordings of mutant CDKL5 neurons at DIV7, DIV14 and DIV21 
respectively.  
Abbreviations: CDKL5: cyclin dependent kinase like five, WT: wild type, DIV: days in vitro, iPS: 
induced pluripotent stem cells 
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Figure 4.3: Induced activity levels of CDKL5 iPS derived cortical neurons mature over three 
weeks in Synaptojuice 
Pie charts, accompanied by exemplary recordings, showing the levels of induced activity 
measured from iPS derived neurons harboring the wild type CDKL5 and the c.1375C>T p.Q459X 
mutant CDKL5 during whole cell patch clamp experiments, during maturation in line with the 
Synaptojuice protocol. Experiments were performed at DIV7, DIV14 and DIV21 to chart the 
maturation of the cells. The pie charts depict the proportions of cells exhibiting quiet and devoid 
of action potentials (red), incomplete activation of action potentials (yellow), a single action 
potential that results in complete depolarisation of the neuron (green), attempting train activity 
(blue) and trains of induced activity (grey). All exepmplary recordings show the membrane 
potential in response to -10 pA (light blue) and +40 pA (orange).  
A-C: pie charts and exemplary recordings of wild type CDKL5 neurons at DIV7, DIV14 and DIV21 
respectively.  
D-F: pie charts and exemplary recordings of mutant CDKL5 neurons at DIV7, DIV14 and DIV21 
respectively.  
Abbreviations: CDKL5: cyclin dependent kinase like five, WT: wild type, DIV: days in vitro, iPS: 
induced pluripotent stem cells 
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Next, to determine whether the mutant CDKL5 impacted the properties of the induced action 
potentials, the first complete action potential to result from injection of current from each 
induced activity protocol  were examined more closely using my automated spike analysis 
code in MatLab. The mutant CDKL5 line action potential halfwidths at DIV21 (2.986 +/- 0.09 
ms) were significantly smaller than those of the wild type CDKL5 line (3.86 +/- 0.31 ms, p < 
0.05, Figure 4.4A). A general trend towards a smaller halfwidth and, therefore, a more mature 
neuronal phenotype, was also observed between DIV7 and DIV21 in both wild type and 
mutant CDKL5 lines.. The action potential amplitude of mutant CDKL5 neurons (44.96 +/- 2.93 
mV) at DIV14 is significantly lower than the amplitude of action potentials observed in wild 
type neurons (52.17 +/- 2.07 mV, p < 0.05, Figure 4.4B). However, this is reversed by DIV21, 
with the mutant CDKL5 action potential amplitude being significantly higher (62.02 +/- 4.69 
mV) than observed in wild type neurons (50.5 +/- 2.61 mV, p < 0.05, Figure 4.4B). Once again, 
a statistically insignificant trend toward more mature, more positive, action amplitudes as the 
DIV pass is observed. The action potential depolarisation rates did not significantly change for 
both the wild type and mutant CDKL5 lines between DIV7 and DIV14. At DIV21 the wild type 
CDKL5 action potential depolarisation rate was at a level consistent with DIV7 and DIV14 
(43.69 +/- 3.61 V/s). However, the depolarisation rate in mutant CDKL5 cells was significantly 
faster (68.05 +/- 8.2 V/s, p < 0.01, Figure 4.4C). The only significant difference in action 
potential threshold potential was seen at DIV7 (Figure 4.4C); a threshold value of 37.87 +/- 
1.3 mV in wild type CDKL5 cells compared to 31.54 +/- 1.18 mV in mutant CDKL5 cells (p < 
0.01). The action potential repolarisation rate at DIV7 was lower and, therefore, slower in 
mutant CDKL5 cells (-17.35 +/- 1.27 V/s) than in wild type CDKL5 cells (-21.25 +/- 12.8 V/s, p 
< 0.05, Figure 4.4E). The action potential afterhyperpolarisation value was significantly lower 
at DIV7 in mutant CDKL5 (-33.16 +/- 1.92 mV) than in the wild type cells (-38.49 +/- 2.09 mV, 
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p < 0.05, Figure 4.4F). Taken together these data suggest that the  c.1375C>T p.Q459X mutant 
CDKL5 has a small effect on action potential properties; although largely they are comparable 
to their wild type counterparts and mature at a similar rate.  
 
Figure 4.4: Action potential properties of CDKL5 iPS derived cortical neurons mature over 
three weeks in Synaptojuice 
A-F: Bar charts plotting resting action potential half-width (A), amplitude (B), depolarization 
rate (C), threshold potential (D), repolarization rate (E) and afterhyperpolarisation (F) of iPS 
derived neurons harboring both wild type CDKL5 (blue bars) and the c.1375C>T p.Q459X 
mutant CDKL5 (orange bars) matured over a course of 21 days post plating in line with the 
Synaptojuice protocol. Neurons underwent whole cell patch clamp experiments at DIV7, DIV14 
and DIV21 to generate the data shown. 
Data shown here as mean +/- SEM. p* <0.05, p** <0.01 
Abbreviations: CDKL5: cyclin dependent kinase like five, WT: wild type, DIV: days in vitro, iPS: 
induced pluripotent stem cells 
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Lastly, the maturation profiles of voltage-activated sodium and potassium currents were 
investigated using a voltage-step protocol in whole cell patch-clamp experiments, as 
described in Chapter 2, at DIV7, DIV14 and DIV21. Pairing the sodium and potassium currents 
(pA) with the capacitance data generated earlier (pF) allowed calculation of their respective 
Figure 4.5. Maturation of sodium and potassium current densities in CDKL5 iPS derived 
neurons over three weeks in Synaptojuice 
Mean sodium and potassium current density plots obtained during whole cell patch clamp 
experiments.  
A-C: mean current density against voltage plots derived for maximum voltage-activated Na+ 
(blue) and K+ currents (orange) taken from iPS derived cortical neurons harbouring the wild 
type CDKL5 during maturation in line with the Synaptojuice protocol at DIV7, DIV14 and DIV21 
respectively.  
D-F: mean current density against voltage plots derived for maximum voltage-activated Na+ 
(blue) and K+ currents (orange) taken from iPS derived cortical neurons harbouring the 
c.1375C>T p.Q459X mutant CDKL5 during maturation in line with the Synaptojuice protocol at 
DIV7, DIV14 and DIV21 respectively.  
Data shown here as mean +/- SEM.  
Abbreviations: CDKL5: cyclin dependent kinase like five, WT: wild type, DIV: days in vitro, iPS: 
induced pluripotent stem cells 
A B C 
D E F 
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current densities (pA/pF). Surprisingly, potassium current densities did not appear to be 
change significantly during the course of maturation in both mutant and wild type CDKL5 cells 
(Figure 4.5). However, there was a striking differences in the maximum sodium current 
density of the mutant CDKL5 neurons at DIV21 which was above 250 pA/pF, compared to all 
other sodium current densities which were essentially less than to 150 pA/pF (Figure 4.5F). It 
is noted that the sodium curves never reach the reveral potential for sodium. The expected 
reversal potentials, upon extrapolation of the line appear more positive than the sodium 
Figure 4.6. Maturation of sodium availability in CDKL5 iPS derived neurons over three weeks in 
Synaptojuice 
Mean mean fractional conductance (G/Gmax) plots for voltage activation (blue) and inactivation 
(orange) of sodium currents obtained during whole cell patch clamp experiments of iPS derived 
neurons harbouring the wild type CDKL5 and the c.1375C>T p.Q459X mutant CDKL5 during 
maturation in Synaptojuice over 21 days post plating. Peak G/Gmax is indicated by the arrow. 
Individual Vm values are plotted on each graph by the white triangles.  
A-C: mean sodium availability plots of iPS derived neurons harbouring the wild type CDKL5 
recorded at DIV7, DIV14 and DIV21 respectively.  
D-E: mean sodium availability plots of iPS derived neurons harbouring the c.1375C>T p.Q459X 
mutant CDKL5 recorded at DIV7, DIV14 and DIV21 respectively.  
Data shown here as mean +/- SEM. 
Abbreviations: CDKL5: cyclin dependent kinase like five, WT: wild type, DIV: days in vitro, iPS: 
induced pluripotent stem cells 
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reversal potential. This is perhaps caused by calcium influx during the recording, which has a 
considerably more positive reversal potential. The sodium and potassium currents were 
recorded in the same protocol as part of a larger set of protocols whereby it was not 
practicially possible to pharmacologically isolate the sodium and potassium currents.  
 The activation/inactivation profiles of the voltage-activated sodium currents were next 
examined. The sodium availability window was slightly larger at DIV21 than earlier in the 
maturation for both wild type and mutant CDKL5 neurons with fractionally higher G/Gmax 
values, and a higher proportion of neurons with a resting membrane potential falling within 
these windows, than those for DIV7 and DIV14 (Figure 4.6).  
Taken together, these data demonstrate that there are very few striking differences in the 
basic neuronal properties between wild type CDKL5 neurons and mutant CDKL5 neurons 
suggesting that the c.1375C>T p.Q459X mutation in CDKL5 has little impact on the rate and 
extent of maturation profiles of these neurons. This suggest that there are little differences 
between the two neuronal populations or that a component of the Synaptojuice might be 
masking the difference. 
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3.4.2 Removal of BDNF, CHIR99021 and LM22A4 from Synaptojuice medium appears to have 
little effect on basic functional properties of iPSC derived neurons harbouring wild type and 
mutated CDKL5 
Disrupted GSK3b is thought to be central to CDKL5 pathogenesis (Fuchs et al., 2014 p.3, 2015 
p.3, 2018 p.3). As Synaptojuice contains small molecules known to interact with components 
of the GSK3b signalling pathway, it was suggested that these might be masking the disease 
phenotype in mutant CDKL5 cells. To determine whether such small molecules in 
Synaptojuice were indeed masking the disease phenotype, the BDNF, CHIR99021 and 
LM22A4 were removed from the Synaptojuice medium for half of the cells during the final 
Figure 4.7: Passive membrane properties of CDKL5 iPS derived cortical neurons in 
Synaptojuice and Reduced Synaptojuice 
A-C: Bar charts plotting resting membrane potential (A), capacitance (B) and input resistance of 
iPS derived neurons harboring both wild type CDKL5 (blue bars) and the c.1375C>T p.Q459X 
mutant CDKL5 (orange bars) matured over a course of 21 days post plating in line with the 
Synaptojuice protocol. Neurons underwent whole cell patch clamp experiments DIV21 to 
generate the data shown. Half of the cells were switched to reduced Synaptojuice, otherwise 
normal Synaptojuice deficient of BDNF, LM22A4 and CHIR99021, after 14 days post plating.  
Data shown here as mean +/- SEM, p** <0.01 
Abbreviations: CDKL5: cyclin dependent kinase like five, WT: wild type, DIV: days in vitro, iPS: 
induced pluripotent stem cells 
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week of maturation. Whole-cell patch-clamp experiments were then performed and basic 
functional properties were examined, as before.  
  
Figure 4.8: Spontaneous activity levels of CDKL5 iPS derived cortical neurons in Synaptojuice 
and Reduced Synaptojuice 
Pie charts, accompanied by exemplary recordings, showing the levels of spontaneous activity 
measured from iPS derived neurons harboring the wild type CDKL5 and the c.1375C>T p.Q459X 
mutant CDKL5 during whole cell patch clamp experiments at DIV21. Half of the cells were 
switched to Reduced Synaptojuice, otherwise normal Synaptojuice deficient of BDNF, LM22A4 
and CHIR99021, after 14 days post plating whilst the other half were left to mature in 
Synaptojuice. The red segments in the pie charts represent quiet cells devoid of action 
potentials, the yellow represents incomplete activation of action potentials and the green 
represent spontaneous activity where action potentials result in complete depolarisation of the 
neurons crossing 0mV.  
A-B: pie charts and exemplary recordings of wild type CDKL5 neurons at DIV21 respectively 
following maturation in Synaptojuice and Reduced Synaptojuice respectively.  
C-D: pie charts and exemplary recordings of wild type CDKL5 neurons at DIV21 respectively 
following maturation in Synaptojuice and Reduced Synaptojuice respectively.  
Data shown here as mean +/- SEM 
Abbreviations: CDKL5: cyclin dependent kinase like five, WT: wild type, DIV: days in vitro, iPS: 
induced pluripotent stem cells 
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Figure 4.9: Induced activity levels of CDKL5 iPS derived cortical neurons in Synaptojuice and 
Reduced Synaptojuice 
Pie charts, accompanied by exemplary recordings, showing the levels of induced activity 
measured from iPS derived neurons harboring the wild type CDKL5 and the c.1375C>T p.Q459X 
mutant CDKL5 during whole cell patch clamp experiments, during maturation in line with the 
Synaptojuice protocol. Half of the cells were were switched to Reduced Synaptojuice, otherwise 
normal Synaptojuice deficient of BDNF, LM22A4 and CHIR99021, after 14 days post plating whilst 
the other half were left to mature in Synaptojuice. Experiments were performed at DIV21. The pie 
charts depict the proportions of cells exhibiting quiet and devoid of action potentials (red), 
incomplete activation of action potentials (yellow), a single action potential that results in 
complete depolarisation of the neuron (green), attempting train activity (blue) and trains of 
induced activity (grey).  
A-B: pie charts and exemplary recordings of wild type CDKL5 neurons at DIV21 respectively 
following maturation in Synaptojuice and Reduced Synaptojuice respectively.  
C-D: pie charts and exemplary recordings of wild type CDKL5 neurons at DIV21 respectively 
following maturation in Synaptojuice and Reduced Synaptojuice respectively.  
Data shown here as mean +/- SEM.  
Abbreviations: CDKL5: cyclin dependent kinase like five, WT: wild type, DIV: days in vitro, iPS: 
induced pluripotent stem cells 
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The control group data (regular Synaptojuice) are included from the data taken before the 
change in protocol (removal of GSK3b modulators present in Synaptojuice) and are 
reproduced from Figures 4.1 through 4.6, for a detailed explanation of the results see 4.4.1. 
Firstly, the passive membrane properties (resting membrane potential, input resistance and 
capacitance) were examined. No significant differences were observed in resting membrane 
potential (Figure 7A) and input resistance (Figure 4.7B). However, capacitance was 
significantly smaller in the mutant CDKL5 cells (13.66 +/- 11.68 pF) than the wild type cells in 
reduced Synaptojuice (25.97 +/- 3.67 pF, p < 0.01, Figure 4.7C). Taken together, these data 
suggest that removal of modulators of GSK3b has little difference on passive membrane 
properties. However, the mutant CDKL5 cells have a smaller capacitance suggestive of cells 
with a smaller soma and fewer, less extensive, projections.  
Next, to determine whether removal of GSK3b modulators present in Synaptojuice would 
alter the levels of spontaneous and induced activity seen in mutant and wild type cells, the 
respective levels of activity were recorded, as before. Spontaneous activity was observed in 
current-clamp mode (I = 0) of the whole-cell patch clamp configuration and classified as either 
quiet, incomplete activation or spontaneous (as described in Chapter 2). The proportion of 
cells displaying spontaneous activity in wild type cells remained comparable in Synaptojuice 
(45 %, Figure 4.8A) and Reduced Synaptojuice (32 %, Figure 4.8B). However, the proportion 
of cells displaying spontaneous activity in mutant CDKL5 cells in reduced Synaptojuice was 
reduced from 71% to 33% (Figure 4.8C-D). These data suggest that removal of GSK3b 
modulators makes very little difference to wild type CDKL5 neurons. However, it results in 
reduced the level of spontaneous activity seen in mutant CDKL5 cells.  
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Induced activity was then examined during a current-step protocol (from -70mV, as described 
in Chapter 2) and classified as either quiet, incomplete activation, single, single attempting 
train or train activity The proportion of cells exhibiting trains of activity increased in wild type 
CDKL5 cells when Synaptojuice was reduced (47 % to 60 %, Figure 4.9A-B). This was also 
observed in the mutant CDKL5 line to a similar degree (47 % to 63 %, Figure 4.9C-D). These 
results imply that removal of GSK3b modulators present in Synaptojuice increases the 
proportion of cells exhibiting trains of activity in both wild type and mutant CDKL5 neurons 
to a similar degree.  
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Detailed spike analysis showed that the action potential halfwidth, which was already shown 
to be significantly different between wild type and mutant CDKL5 neurons in regular 
Synaptojuice at DIV21 (p < 0.05, reproduced from Figure 4.4A) was not affected by removal 
Figure 4.10: Action potential properties of CDKL5 iPS derived cortical neurons in Synaptojuice and 
Reduced Synaptojuice 
A-F: Bar charts plotting resting action potential half-width (A), amplitude (B), depolarization rate (C), 
threshold potential (D), repolarization rate (E) and afterhyperpolarisation (F) of iPS derived neurons 
harboring both wild type CDKL5 (blue bars) and the c.1375C>T p.Q459X mutant CDKL5 (orange bars) 
matured over a course of 21 days post plating in line with the Synaptojuice protocol. Half of the cells 
were switched to Reduced Synaptojuice, otherwise normal Synaptojuice deficient of BDNF, LM22A4 
and CHIR99021, after 14 days post plating whilst the other half were left to mature in Synaptojuice. 
Whole cell patch clamp experiments were performed at DIV21.  
Data shown here as mean +/- SEM. p* <0.05, p** <0.01 
Abbreviations: CDKL5: cyclin dependent kinase like five, WT: wild type, DIV: days in vitro, iPS: 
induced pluripotent stem cells 
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of Synaptojuice components thought to interact with GSK3b (Figure 4.10A). In complete 
Synaptojuice, where the depolarisation rate was already shown to be significantly faster in 
the mutant CDKL5 cells compared to their WT counterparts (p < 0.01, reproduced from Figure 
4.4B), reduced Synaptojuice still supported this significant difference (42.64 +/- 1.7 V/s in wild 
type cells and 57.88 +/- 4.59 V/s in mutant cells, p < 0.05, Figure 4.10B). The difference 
between mutant CDKL5 action potential amplitude and wild type amplitude was no longer 
statistically significantly different in reduced Synaptojuice (Figure 4.10C) having already been 
shown to be significant in complete Synaptojuice (p < 0.05, reproduced from Figure 4.4C). No 
significant differences when Synaptojuice was removed were observed in action potential 
threshold (Figure 4.10D), repolarisation rate (Figure 4.10E) and afterhyperpolarisation 
potential (Figure 4.10F). Taken together, these data suggest that removal of GSK3b from 
Synaptojuice has little to no effect on the properties of the individual induced action 
potentials in either wild type and mutant CDKL5 neurons at DIV21. 
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Figure 4.11: Sodium and potassium current densities in CDKL5 iPS derived neurons in 
Synaptojuice and Reduced Synaptojuice 
Mean sodium and potassium current density plots obtained during whole cell patch clamp 
experiments. Half of the cells were switched to Reduced Synaptojuice, otherwise normal 
Synaptojuice deficient of BDNF, LM22A4 and CHIR99021, after 14 days post plating whilst the 
other half were left to mature in Synaptojuice. Whole cell patch clamp experiments were 
performed at DIV21.  
A-C: mean current density against voltage plots derived for maximum voltage-activated Na+ (blue) 
and K+ currents (orange) taken from iPS derived cortical neurons harbouring the wild type CDKL5.  
D-F: mean current density against voltage plots derived for maximum voltage-activated Na+ (blue) 
and K+ currents (orange) taken from iPS derived cortical neurons harbouring the c.1375C>T 
p.Q459X mutant CDKL5.  
Data shown here as mean +/- SEM.  
Abbreviations: CDKL5: cyclin dependent kinase like five, WT: wild type, DIV: days in vitro, iPS: 
induced pluripotent stem cells 
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Figure 4.12: Sodium availability in CDKL5 iPS derived neurons in Synaptojuice and Reduced 
Synaptojuice 
Mean mean fractional conductance (G/Gmax) plots for voltage activation (blue) and 
inactivation (orange) of sodium currents obtained during whole cell patch clamp experiments 
of iPS derived neurons harbouring the wild type CDKL5 and the c.1375C>T p.Q459X mutant 
CDKL5.  Peak G/Gmax is indicated by the arrow. Individual Vm values are plotted on each 
graph by the white triangles. Half of the cells were switched to Reduced Synaptojuice, 
otherwise normal Synaptojuice deficient of BDNF, LM22A4 and CHIR99021, after 14 days 
post plating whilst the other half were left to mature in Synaptojuice. Whole cell patch clamp 
experiments were performed at DIV21  
A-C: mean sodium availability plots of iPS derived neurons harbouring the wild type CDKL5.  
D-E: mean sodium availability plots of iPS derived neurons harbouring the c.1375C>T 
p.Q459X mutant CDKL5.  
Data shown here as mean +/- SEM.  
Abbreviations: CDKL5: cyclin dependent kinase like five, WT: wild type, DIV: days in vitro, 
iPS: induced pluripotent stem cells 
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Lastly, the voltage-activated sodium and potassium currents were interrogated using a 
voltage-step protocol (as described in Chapter 2). Figure 4.11 shows that removal of GSK3b 
modulators appears to have very little impact on sodium and potassium current density 
properties in both wild type and mutant cells. This also appears to be true for the 
activation/inactivation profiles represented in Figure 4.12. Sodium availability windows, 
G/Gmax peaks and proportion of cells within the sodium availability window remained 
roughly consistent despite removal of GSK3b modulators in Synaptojuice. Taken together, 
these data suggest that the presence or absence of GSK3b modulators in Synaptojuice has 
little bearing on sodium and potassium currents in patient iPSC derived neurons harbouring 
either wild type or mutant CDKL5.  
When considering all of these data together, few striking differences are seen in the basic 
properties between wild type CDKL5 neurons and mutant CDKL5 neurons when the 
modulators of GSK3b are removed. This suggests BDNF, LM22A4 and CHIR99021 are unlikely 
to be masking any functional differences, or that whole cell patch clamp recordings are not 
able to reveal these differences.  
  
 O.G. Steele 
BIOSI PG 1757384  75 
4.4.3 Mutated CDKL5 has little impact on the ability of iPSC-derived to display network activity 
at DIV21 
Interrogation of the differences between wild type and mutant CDKL5 neurons via whole-cell 
patch clamp experiments revealed few differences between their maturation profiles. 
Although whole-cell patch-clamp is an invaluable tool to investigate the membrane 
properties of electrically active cells, this technique can only investigate a single cell at a time. 
As epilepsy is, in part, the result of changes in network activity across huge populations of 
neurons, patient iPS derived neural progenitor cells, were plated onto commercially available 
MEA plates in order to investigate network activity at DIV21. The spike raster plots clearly 
display unsynchronised activity across all wells in both wild type CDKL5 neurons (Figure 13A) 
and mutant CDKL5 neurons (Figure 4.14A), supported by similar three-dimensional spike 
count plots (Figures 4.13C and 4.14C) and cross correlation matrices (Figures 4.13B and 
4.14B). Mean synchronisation indexes from the two populations the two were also not 
significantly different. Taken together, these data suggest that this mutation in CDKL5 does 
not lead to any significant alteration in network activity in patient iPS derived cortical neurons, 
a conclusion consistent with the single cell data derived from whole-cell patch-clamp 
recordings.  
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Figure 4.13: Exemplary MEA analysis from wild type CDKL5 neurons at DIV21 in Synaptojuice 
iPS derived neurons harboring the wild type CDKL5 were plated on commercially available MEA plates 
and matured in line with the Synaptojuice protocol and recorded at DIV21   
A: Spike raster plots showing an individual line representing a spike that exceeded five standard 
deviations of the background noise from each electrode (y axis) over time in a single well.  
B: cross correlation matrix heat map showing level of synchronization between electrodes and mean 
synchronicity index between 0-5 (top) calculated for the top left triangle (bottom right triangle is a 
mirror image).  
C: 3D bar plot displaying spike count per electrode from the well.  
Abbreviations: CDKL5: cyclin dependent kinase like five, DIV: days in vitro, iPS: induced pluripotent 
stem cells, MEA: multi electrode array 
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Figure 4.14: Exemplary MEA analysis from mutant CDKL5 neurons at DIV21 in Synaptojuice 
iPS derived neurons harboring the c.1375C>T p.Q459X mutant CDKL5 were plated on 
commercially available MEA plates and matured in line with the Synaptojuice protocol and 
recorded at DIV21.  
A: Spike raster plots showing an individual line representing a spike that exceeded five standard 
deviations of the background noise from each electrode (y axis) over time in a single well.  
B: cross correlation matrix heat map showing level of synchronization between electrodes and 
mean synchronicity index between 0-5 (top) calculated for the top left triangle (bottom right 
triangle is a mirror image).  
C: 3D bar plot displaying spike count per electrode from the well.  
Abbreviations: CDKL5: cyclin dependent kinase like five, DIV: days in vitro, iPS: induced 
pluripotent stem cells, MEA: multi electrode array 
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4.4.4 Removal of BDNF, CHIR99021 and LM22A4 from Synaptojuice medium reveals hyper 
synchronised network activity in the mutant-CDKL5 harbouring neurons  
The removal of BDNF, CHIR99021 and LM22A4, (termed ‘Reduced Synaptojuice’) revealed 
only small differences in single cell properties. To investigate the effect of removal of these 
small molecules on neuronal network activity, thought to be key in epilepsy, MEA recordings 
were made following switching from Synaptojuice to Reduced Synaptojuice for the final week 
of maturation. The spike raster plot of the mutant CDKL5 MEA activity in Reduced 
Synaptojuice shows striking hyper-synchronised network activity (highlighted in red, Figure 
4.16A). Although, the total three-dimensional spike count plots do not differ dramatically 
between wild type (Figure 4.15C) and mutant (Figure 4.16C), the hyper-synchronicity as a 
result of Synaptojuice reduction is further highlighted by the vastly different cross correlation 
matrices (Figure 4.15B and Figure 4.16 B). Figure 4.17 shows the mean synchronisation index 
of the wild type and mutant CDKL5 lines in both Synaptojuice and Reduced Synaptojuice. The 
mean synchronisation index of the mutant CDKL5 neurons in Reduced Synaptojuice (1.78 +/- 
0.39) was significantly higher than the synchronisation index of both the wild type neurons in 
Reduced Synaptojuice (0.14 +/- 0.11, p < 0.01) and the mutant CDKL5 neurons in Synaptojuice 
(0.04 +/- 0.01, p < 0.001). Taken together, these data strongly suggest that removal of the 
modulators of GSK3b (BDNF, CHIR99021 and LM22A4) unmasks hyper-synchronised network 
activity, a characteristic disease phenotype of CDKL5-deficieny which is visible upon MEA 
analyses.  
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Figure 4.15: Exemplary MEA analysis from wild type CDKL5 neurons at DIV21 in Reduced 
Synaptojuice 
iPS derived neurons harboring the wild type CDKL5 were plated on commercially available 
MEA plates and matured in line with the Synaptojuice protocol and recorded at DIV21. The 
cells were switched to Reduced Synaptojuice, otherwise normal Synaptojuice deficient of 
BDNF, LM22A4 and CHIR99021, after 14 days post plating.  
A: Spike raster plots showing an individual line representing a spike that exceeded five 
standard deviations of the background noise from each electrode (y axis) over time in a 
single well.  
B: cross correlation matrix heat map showing level of synchronization between electrodes 
and mean synchronicity index between 0-5 (top) calculated for the top left triangle (bottom 
right triangle is a mirror image).  
C: 3D bar plot displaying spike count per electrode from the well.  
Abbreviations: CDKL5: cyclin dependent kinase like five, DIV: days in vitro, iPS: induced 
pluripotent stem cells, MEA: multi electrode array 
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Figure 4.16: Exemplary MEA analysis from mutant CDKL5 neurons at DIV21 in Reduced 
Synaptojuice 
iPS derived neurons harboring c.1375C>T p.Q459X mutant CDKL5 were plated on 
commercially available MEA plates and matured in line with the Synaptojuice protocol and 
recorded at DIV21. The cells were switched to Reduced Synaptojuice, otherwise normal 
Synaptojuice deficient of BDNF, LM22A4 and CHIR99021, after 14 days post plating.  
A: Spike raster plots showing an individual line representing a spike that exceeded five 
standard deviations of the background noise from each electrode (y axis) over time in a single 
well. Synchronized bursts are highlighted in red.  
B: cross correlation matrix heat map showing level of synchronization between electrodes 
and mean synchronicity index between 0-5 (top) calculated for the top left triangle (bottom 
right triangle is a mirror image).  
C: 3D bar plot displaying spike count per electrode from the well.  
Abbreviations: CDKL5: cyclin dependent kinase like five, DIV: days in vitro, iPS: induced 
pluripotent stem cells, MEA: multi electrode array 
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Figure 4.17: WT & Mutant mean synchronization index in complete and reduced 
Synaptojuice at DIV21. 
iPS derived neurons harboring c.1375C>T p.Q459X mutant CDKL5 (orange) and wild type 
CDKL5 (blue) were plated on commercially available MEA plates and matured in line 
with the Synaptojuice protocol and recorded at DIV21. Half of the cells were switched 
to Reduced Synaptojuice otherwise normal Synaptojuice deficient of BDNF, LM22A4 
and CHIR99021, after 14 days post plating whilst the other half were left to mature in 
Synaptojuice prior to recording. Data shown here as mean +/- SEM. p* <0.05, p** <0.01 
Abbreviations: CDKL5: cyclin dependent kinase like five, DIV: days in vitro, iPS: induced 
pluripotent stem cells, MEA: multi electrode array, WT: wild type 
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3.5 Discussion & Conclusion 
 
 
3.5.1 CDKL5 and GSK3b signalling 
 
 
To date the precise physiological role of CDKL5, a serine-threonine kinase, remains unclear. 
Roles in neuronal morphogenesis are amongst the most commonly reported potential 
functions, with decreased dendritic arborisation and spine density seen in vivo (Chen et al., 
2010a; Ricciardi et al., 2012; Fuchs et al., 2014; Della Sala et al., 2016) and in vitro (Ricciardi 
et al., 2012; Zhu et al., 2013). A second commonly implicated role is as a component of the 
GSK3b signalling pathway, as suggested in experiments designed to disrupt GSK3b signalling 
(Wang et al., 2012; Fuchs et al., 2014) and by the beneficial effects of GSK3b inhibition, in vivo 
(Fuchs et al., 2014, 2018). Whilst the data presented in my thesis focus primarily on 
electrophysiological properties, one interesting result stands out. Cellular capacitance, which 
is a reliable indicator of neuronal size and complexity; a larger cell being able to hold more 
charge and is, therefore, said to have a larger capacitance. Figure 4.1C shows that the cellular 
capacitance of both wild type and mutant CDKL5 iPSC-derived neurons mature at a similar 
rate and are not significantly different at any point, suggesting the mutation has no impact 
on neuronal size and complexity. However, when the modulators of the GSK3b (BDNF, 
CHIR99021 and LM22A4) were removed from Synaptojuice, the cellular capacitance was 
significantly smaller in CDKL5 mutant than in WT neurons (Fig.4.7C). Not only does this result 
support the existing literature which suggests a role of CDKL5 in neuronal morphogenesis, 
they also further implicate GSK3b in CDKL5-deficiency.  
CHIR99021 is a well-documented GSK3b inhibitor(Chen et al., 2014; Wu et al., 2015; Huang 
et al., 2017),whereas the inhibitory effect of BDNF and/or LM22A4 on GSK3b is less direct. 
BDNF initiates it’s effect largely through the tropomysin receptor kinase B (TrkB) signalling 
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cascade (Gupta et al., 2014) which in turn actives phosphatidylinositide 3-kinase (PI3K) and 
Akt (otherwise known as protein kinase B). Akt is a serine/threonine kinase that inhibits the 
action of GSK3b through phosphorylation of the Ser9 residue (Hu et al., 2013). Removal of 
BDNF results in reduced TrkB activation and a consequent reduction in GSK3b inactivation. 
LM22A4, a potent TrkB agonist, inhibits the TrkB activation (Massa et al., 2010), therefore 
reducing GSK3b inactivation by the same pathway. Increased GSK3b activation has been 
shown to result in neuronal cell death (Lucas et al., 2001; Mishra et al., 2007) and increased 
sodium currents resulting in increased spontaneous action potentials (Paul et al., 2016), 
markers of neurodegeneration and epilepsy, respectively. Increased sodium currents have 
been reported as a causal factor behind the epilepsy in a related disorder, Dravet’s Syndrome 
(Liu et al., 2013), and decreased neuronal survival is commonly reported in CDKL5 studies 
(Fuchs et al., 2014; Trazzi et al., 2016). Interestingly, decreased microtubule polymerisation 
through inhibition of CRMP2 (Fukata et al., 2002; Yoshimura et al., 2005) has also been 
reported as a consequence of increased GSK3b activation, potentially accounting for the 
decreased dendritic arborisation seen in the literature and decreased cellular capacitance 
seen here. The crucial role of the GSK3b signalling cascade in CDKL5 was further supported 
by the work of Fuchs et al., that highlighted components of the GSK3b pathway downstream 
of PI3K exhibited decreased phosphorylation (Fuchs et al., 2014) in a knockout model of 
CDKL5 deficiency. As the mutation studied here is a nonsense mutation (Zhao et al., 2014) 
resulting in either decreased levels of the protein or non-functional versions of it, it can be 
expected that the mutation would also result in decreased phosphorylation of GSK3b. It is as 
yet unclear whether the serine/threonine kinase activity of CDKL5 works directly or indirectly 
on GSK3b.  
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Another target implicated in the pathogenesis of CDKL5-deficiency is histone deacetylase 4 
(HDAC4). HDAC4 is thought to play crucial roles in the transcriptional regulation of processes 
essential for synaptic plasticity (Sando et al., 2012), a process thought to be crucial in learning 
and memory. CDKL5-deficiency patients often show striking cognitive deficits. Much less 
research emphasis is focused on HDAC4 in CDKL5-deficiency. However, treatment with the 
HDAC4 inhibitor, LMK235, improved both memory performance and neuronal survival in mice 
(Trazzi et al., 2016). 
 
 
3.5.2 Modelling difficult-to-manage epileptic disorders 
 
One of the biggest problems associated with the development of novel therapeutics for 
CDKL5-deficiency is that none of the existing animal models exhibit the most defining clinical 
feature of CDKL5-deficiency: epilepsy (Chen et al., 2010b; Ricciardi et al., 2012; Amendola et 
al., 2014; Della Sala et al., 2016). A combination of the consequences of increased GSK3b 
activity, caused by decreased inactivation by loss of CDKL5 kinase activity, could lead to the 
life-limiting epilepsy seen in patients. This is further supported by the striking differences seen 
in network activity when GSK3b inhibitors are removed from the media (Fig4.16 and Fig.4.17). 
Whilst synchronisation is widely accepted as a fundamental part of physiology and 
pathophysiology within the CNS (Varela et al., 2001), hyper-synchronised activity is more 
commonly associated with epilepsy (Lehnertz et al., 2009). Seen in Figure 16, the repeated 
synchronised activity recorded at every electrode in the well can be seen as hyper-
synchronicity. Furthermore, as this hyper-synchronicity is only seen when GSK3b inhibitors 
are removed from the maturation media and, therefore, no longer masking the effect of 
decreased CDKL5 related GSK3b inhibition, it can be suggested that the hyper-synchronised 
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network activity visible on the MEA could be used a surrogate of the epileptic  phenotype of 
CDKL5-deficienc in drug-screening studies. 
It is currently unclear how decreased inactivation, and subsequently increased activity, of 
GSK3b can lead to the epilepsy seen in patients and hypersynchronization in the MEA studies. 
Paul et al., suggested that increased GSK3b activity caused increased levels of spontaneous 
activity by altering the threshold potential and, therefore, increasing spontaneous activity 
(Paul et al., 2016). It was noted that neurons with a mutant CDKL5 exhibited increased levels 
of spontaneous activity at all stages of maturation (Figure 4.2), potentially supportive of Paul’s 
suggestion. This is especially interesting considering no clear difference in resting Vm or input 
resistance suggestive of increased presynaptic input from neighbouring cells. However, in the 
absence of GSK3b inhibitors (and therefore increased GSK3b activity) the level of 
spontaneous activity dropped to that of wild type levels (Fig.4.8). Increased sodium currents 
(Fig.4.11) and altered threshold potentials (Fig.4.10) as a result of GSK3b dis-inhibition were 
not observed during the experiments conducted in this study. Furthermore GSK3b dis-
inhibition appeared to reduce the level of spontaneous activity closer to that of wild type 
neurons (Figure 8). Seemingly contradictorily, Ricciardi et al., suggested that decreased CDKL5 
levels resulted in decreased the numbers of excitatory synapses and, as a consequence, fewer 
miniature excitatory post-synaptic currents (Ricciardi et al., 2012). CDKL5’s reported 
interactions with post-synaptic density protein 95 (PSD-95) (Ricciardi et al., 2012; Della Sala 
et al., 2016) and amphiphysin 1 (Sekiguchi et al., 2013), proteins involved in synapse 
formation and vesicle endocytosis, seem to support the suggestions made by Ricciardi et al., 
yet do not shed light on how defects in CDKL5 can lead to epilepsy seen in patients. However, 
the results presented herein support the existing literature surrounding the central role of 
GSK3b in the pathogenesis of CDKL5-deficiency. 
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The promising early results shown here suggest that the mutant CDKL5 did not appear to 
cause functional differences on a single cell level (Fig.4.1 through Fig.4.6). However, when 
recording networks of activity on MEA plates, significant differences were seen in 
synchronicity. This is of particular interest as these data suggest human iPSC derived from 
patients are able to model the epilepsy seen in patients, a key feature missing from animal 
studies. The presence of such a defining clinical feature validates the use of patient iPSC as a 
model for CDKL5-deficiency. The presence of this phenotype on the MEA present an exciting 
opportunity to test the efficacy of existing therapeutic targets such as the HDAC4 inhibitor 
LMK235 (Trazzi et al., 2016), GSK3b inhibitor Tideglusib (Fuchs et al., 2018) and the positive 
allosteric GABA modulator Ganaxolone (Carter et al., 1997) currently in clinical trials 
(ClinicalTrials.gov, 2015). Furthermore, the presence of this previously difficult to model 
phenotype allows for the testing of novel therapeutic compounds on a high throughput scale 
not previously available. 
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Chapter 5 - Stem cell based cell replacement therapies for 
Huntington’s Disease 
 
 
5.1 Introduction 
The fatal neurodegenerative condition Huntington’s Disease (HD) is caused by a mutation in 
the huntingtin protein. Under physiological circumstances, the gene responsible for 
production of the huntingtin protein contains < 35 CAG repeats (Rubinsztein et al., 1996; 
Craufurd et al., 2001) that are translated into a polyglutamine sequence (PolyQ). However, 
patients show incomplete penetrance between 36 and 40 CAG repeats and complete 
penetrance above 40 CAG repeats. This expanded PolyQ sequence results in severe 
movement, cognitive and psychiatric impairment (Craufurd et al., 2001) at a mean age of 
onset of 35 and is usually fatal in 15-20 years following onset of symptoms. The severity and 
age of onset has been reported to scale with the length of CAG repeat (Rubinsztein et al., 
1996), whilst environmental and other genetic factors are thought to influence this further 
(Rosenblatt et al., 2001; Wexler et al., 2004; Chattopadhyay et al., 2005). HD contributes to 
dementia, the single leading cause of death in the UK (Office for National Statistics, 2016), 
and as no effective therapy exists there is a pressing demand for research into innovative 
therapies.  
Key to understanding to the HD pathogenesis is understanding the physiological role of  the 
huntingtin protein. However, this remains elusive despite extensive studies. Huntingtin has 
thus far been implicated in multiple facets of neuronal development. Huntingtin KO mice 
perish prior to proper nervous system development, suggesting a vital role in embryonic 
development (Nasir et al., 1995). The protein has also been closely associated with BDNF 
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production (Zuccato et al., 2001) and transport (Gauthier et al., 2004), as well as anti-
apoptotic functions (Dragatsis et al., 2000; Zhang et al., 2003; Leavitt et al., 2006). Whilst all 
of these roles could potentially produce a phenotype consistent with that seen in HD, in man 
it appears that mutant huntingtin has a toxic gain of function (Walker, 2007), due to the 
formation of toxic protein aggregates, rather than a loss of function.  
Perhaps the most defining feature of HD is the neuronal cell loss, seen earliest and most 
strikingly in medium spiny neurons (MSNs) of the striatum. It is thought that the mutant 
huntingtin aggregates contribute to this cell loss the increased caspase 3 activation (Zhang et 
al., 2006). Another hallmark of early stage HD is an apparent increased level of quinolinate in 
the striatum (Guidetti et al., 2004), a metabolite produced in the kynurenine pathway and 
potent excitotoxin within the CNS. Other metabolites of the kynurenine pathway include 3-
hydroxykynurenine (3-HK) and kynurenate. Of interest is 3-HK, suggested to produce “HD-
like” MSN cell death via free radical production (Okuda et al., 1996) and potentiation of the 
excitotoxic properties of quinolinate (Guidetti and Schwarcz, 2008). Quinolinate, or quinolinic 
acid, is believed to exert its toxic effects  through excessive activation of N-methyl-D-
aspartate receptors NMDARs (Perkins and Stone, 1983; Schwarcz and Köhler, 1983) and 
through the increase of glutamate in the synaptic microenvironment. Both increased 
presynaptic release of glutamate and decreased reuptake of glutamate (Tavares et al., 2000, 
2002) contribute to elevated synaptic glutamate levels. The elevated glutamate leads to 
chronic NMDAR activation, subsequently resulting in massive Ca2+ influx.  Ca2+ influx is vital 
during synaptic communication and long term potentiation, yet unregulated Ca2+ influx can 
initiate a cascade of reactions resulting in apoptotic cell death (Dong et al., 2009; Ndountse 
and Chan, 2009). The cell loss likely accounts for most of the HD phenotype, yet is not the 
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only contributing factor. Indeed, impaired α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic 
acid receptor (AMPAR) receptor trafficking has been reported to be impaired in HD potentially 
accounting for some of the cognitive impairment seen (Mandal et al., 2011; Zhang et al., 
2018). 
Whilst a small number of therapeutic targets exist to manage the symptoms of HD, such as 
anticonvulsants and antidepressants, no effective therapy exists that prevents or slows with 
the underlying neuronal loss. A cell replacement therapy, aimed at replacing the neurons lost 
to the disease process, may provide novel therapeutic strategy. Stem cells have the unique 
ability of being able to differentiate into any other cell type (dependant on their state of 
differentiation) and thus represent a tantalising possible solution to this problem. ‘Repair HD’ 
is a consortium of European universities collaborating over 5 years towards a stem cell based 
cell replacement therapy for HD (https://huntingtonstudygroup.org/hd-insights/repair-hd/).  
Having successfully developed protocols to differentiate stem cells into MSNs (Nicoleau et al., 
2013; Arber et al., 2015; Noakes et al., 2015), the next stage was the transplantation of stem 
derived neural progenitors into an HD animal model in the hope this will inform the work 
needed to progress towards first-in-man clinical trials.  
Animal models of HD consistently show behavioural improvements following embryonic 
(Campbell et al., 1993; Döbrössy and Dunnett, 2006; Aubry et al., 2008; Ma et al., 2012; 
Reidling et al., 2018) and foetal (McBride et al., 2004; Ryu et al., 2004) stem cell derived grafts. 
This behavioural improvement has been partially obtained in early transplant studies in 
human patients (Bachoud-Lévi et al., 2000; Gaura et al., 2004; Reuter et al., 2008). Despite 
several of these studies suggesting connectivity between host and graft tissue using 
immunohistochemistry (Ma et al., 2012), 18F-fleurodeoxyglucose (18F-FDG)-positron 
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emission tomography (Gaura et al., 2004) and high performance liquid chromatography 
(Campbell et al., 1993), there is an almost complete lack of functional electrophysiological 
recordings supporting this suggestion. For a therapy to be fully effective, the engrafted 
neuronal progenitors must differentiate into functional MSNs and must electrophysiologically 
communicate with the host striatum.  
 O.G. Steele 
BIOSI PG 1757384  91 
5.2 Aims & Rationale 
Transplant therapies have shown promise in a similar neurodegenerative condition, 
Parkinson’s Disease, and this project hopes to replicate this in HD. For any transplant therapy 
to be truly effective, functional synaptic integration is required. The best method to 
interrogate synaptic activity remains to be electrophysiology. This project will therefore 
electrophysiologically assess, via whole cell patch clamp in vitro and extracellular field 
potential recordings ex vivo, the functional integration of stem cell derived grafts into the 
striatum of a  quinolinic acid lesioned rat model of Huntington Disease. 
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5.3 Methodology 
Lister hooded rats (Charles River) were maintained, strereotaxically unilaterally lesioned via 
quinolinic acid (Sigma), grafted with a variety of stem cell-derived neuronal progenitors and 
culled prior to recordings in line with Home Office regulations by a fully trained colleague, Dr 
Ana Garcia Aguirre. The stem cells of origin were either human embryonic stem cell (hESC) 
neural progenitor cells, human whole ganglionic eminence (hWGE) cells of rat WGE (rWGE) 
cells. The stem cells were also transfected with green fluorescent protein (GFP) and luciferase 
via a trained colleague Dr Ngoc-Nga Vinh, with the assistance and supervision of Dr Amit 
Jathoul. Animals were culled, as described in Chapter 2 of this thesis, at 22 weeks (+/- 2 weeks) 
post transplantation for functional recordings. A detailed explanation of the 
electrophysiological experiments performed can also be found in Chapter 2 of this thesis.  
It is important to note that very few previous studies have been performed/reported of 
striatal recordings in rat brain slice, making it important that lesion-only animals were 
included in the experimental strategy. Furthermore, unilateral lesions were employed in 
order that a non-lesioned, contralateral striatum was left intact for intra-slice comparisons 
and control recordings. Thus, the experimental groups were as follows; Group L consisted of 
lister hooded rats subject only to a single unilateral lesion (n = 16); Group A consisted of lister 
hooded rats subject to unilateral lesion, and subsequent grafting of hESC derived neural 
progenitors, transfected with GFP and luciferase, into the lesion site (n = 16); Group B 
consisted of lister hooded rats subject to unilateral lesion, and subsequent grafting of hWGE 
derived neural progenitors, transfected with GFP and luciferase, into the lesion site (n = 16); 
Group C consisted of lister hooded rats subject to unilateral lesion, and subsequent grafting 
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of rWGE derived neural progenitors, transfected with GFP and luciferase, into the lesion site 
(n = 16);  
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5.4 Results 
5.4.1 Intrastriatal synaptic transmission is AMPAR dependant 
Prior to lesioning and grafting, it was important to establish the contributing factors of basal 
intrastriatal synaptic transmission. To do this, coronal slices were cut and extracellular field 
potential recordings were performed intrastriatally during perfusion of receptor 
antagonists. Figure 5.1B shows that following the recording of baseline activity (0.978 +/- 
0.031 mV, n = 11), exposure to 5 µM 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzoquinoxaline 
(NBQX), a potent AMPAR antagonist, significantly reduced the peak amplitude of post-
synaptic field potentials  to 0.09 ± 0.01 mV, n = 11, P < 0.01). Co-application of 500 nM TTX, a 
potent and highly selective blocker of several classes of voltage-gated sodium channels, did 
not significantly  reduce activity further (0.0151 +/- 0.0142, n = 11, P = 0.1,). It is important to 
note that NBQX exposure only impaired the post-synaptic field potential and not the afferent 
fibre volley, which itself is pre-synaptically mediated, as indicated by the exemplary traces in 
Figure 5.1C. Taken together, these data imply that intrastriatal synaptic transmission is 
mediated almost entirely by AMPARs, supporting the findings of Skiteva et al (Skiteva et al., 
2018). 
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Figure 5.1: Intrastriatal synaptic transmission is AMPA-R dependent 
Extracellular field potential recordings were performed intrastriatally in the contralateral 
hemisphere to interrogate healthy striatal function. 
A: Intrastriatal fEPSP peak amplitude as compared to the average baseline peak amplitude (first 5 
minutes of recording) following NBQX exposure (at 5 minutes) and TTX exposure (at 15 minutes),(n 
= 11). 
B: Mean values +/- SEM during the final 2 minutes of the fEPSP peak amplitude compared to the 
baseline prior to drug exposure (blue, n = 11), following NBQX exposure (orange, n = 11) and TTX 
exposure (yellow, n = 11). 
C: Exemplary fEPSP traces before drug exposure (blue), following NBQX exposure (orange) and 
following TTX (yellow). 
Data shown as mean values +/- SEM. p** < 0.01. 
Abbreviations: fEPSP: field excitatory post synaptic potential, NBQX: 2,3-dihydroxy-6-nitro-7-
sulfamoyl-benzo[f]quinoxaline, TTX: Tetrodotoxin, AMPA-R: α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid receptor 
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5.4.2 Quinolinic acid lesions impair synaptic transmission 
To determine the effect of quinolinic acid lesion on the previously described intrastriatal 
synaptic transmission, coronal slices were taken and extracellular intrastriatal field potential 
recordings were performed in the ipsilateral hemisphere to the lesion and then compared to 
the contralateral hemisphere. Figure 5.2A shows a marked difference upon visual inspection 
through an infra-red camera. This visual disturbance also translated to a functional 
impairment. Figure 5.2B shows that intrastriatal synaptic transmission was significantly 
impaired in the hemisphere ipsilateral to the quinolinic acid lesion (-0.23± 0.03 mV, n = 8) 
when compared to the contralateral hemisphere (-0.79 ± 0.03 mV, n = 57, P < 0.05,  Student’s 
t-test). These data suggest the quinolinic acid lesions significantly impair Intrastriatal synaptic 
function and validate its use as an approach to generate an animal models of HD in this study. 
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Figure 5.2: Quinolinic acid lesions significantly impair synaptic transmission in the rat 
striatum 
Extracellular field potential recordings were performed intrastriatally in the contralateral 
hemisphere and in the lesioned hemisphere and images taken. 
A: Healthy rat striatum (top left) and the quinolinic acid lesioned striatum (bottom left) 
imaged imaged through an infra-red camera.  
B: Intrastriatal fEPSP peak amplitudes in both the healthy (blue, n = 57) and lesioned 
hemispheres (red, n = 8).  
Data shown as mean values +/- SEM. p* < 0.05. 
Abbreviations: QA: quinolinic acid, fEPSP: field excitatory post synaptic potential, *: p < 0.05 
 
 O.G. Steele 
BIOSI PG 1757384  98 
5.4.3 rWGE derived MSNs display the most mature functional properties at DIV21 in vitro  
To validate the efficacy of stem cell differentiation to medium spiny neurons, and to act as a 
quality control, the stem cell derived neural progenitor cells (hESC/hWGE/rWGE) were plated 
onto glass coverslips and matured using the Synaptojuice protocol (Telezhkin et al., 2016). As 
already discussed in Chapter 5 at DIV21, the basic functional properties of the neurons were 
then interrogated using whole-cell patch-clamp electrophysiology. It is important to note, 
that these neural progenitors are from the same batches as used in the subsequent 
transplantation therapies, and were plated at the same time as transplantation (+/- 2 hours). 
Plotting the basic functional properties from each group on a polar plot normalised to the 
most mature value of each respective property, revealed rWGE-derived MSNs as the most 
mature in all properties (Fig.5.3A). rWGE-derived MSNs produced neurons were also capable 
of spontaneous activity (Fig.5.3C). These data suggest the rWGE-derived neural progenitor 
cells produce the most mature MSN-like neurons and may, therefore, be expected to provide 
the greatest functional improvement in the grafted animals.   
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Figure 5.3: rWGE cells appear to produce MSN populations with the most mature functional 
properties 
Basic functional properties of the neural progenitors were interrogated via whole cell patch clamp 
recordings at DIV21 post plating following maturation in line with the Synaptojuice protocol. 
A: A polar plot of all the basic properties obtained during whole-cell patch-clamp recordings from 
each cell line; hESC (blue, n = 16), rWGE (red, n = 14), hWGE (green, n = 15). All properties are 
normalised to their peak of maturity (more negative resting membrane potential, larger capacitance, 
smaller halfwidth etc), the further out therefore indicating the more mature. This is also indicated 
by the maturity bar showing the darker regions to be more mature. SEM bars have been removed 
for clarity.  
B: hESC exemplary recordings of spontaneous activity during whole cell patch clamp recordings in 
current clamp mode (I = 0).  
C: rWGE exemplary recordings of spontaneous activity during whole cell patch clamp recordings in 
current clamp mode (I = 0).  
Abbreviations, hESC: human embryonic stem cells, rWGE: rat whole ganglionic eminence, hWGE: 
human whole ganglionic eminence, DIV: days in vitro, MSN: medium spiny neurons 
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5.4.4 Bioluminescence and GFP facilitate multi-stage graft visualisation  
Should transplantation therapy be translated to human subjects in the future, it would be 
vital to be able to visualise the graft in vivo at multiple stages of development. This is also vital 
for animal studies, in order to be able to check the growth of the graft over time and for 
accurate placement of recording and stimulating electrodes during recordings.  To facilitate 
the multi-stage visualisation of the grafts during in vitro differentiation, in vivo maturation 
and ex vivo in the slices without the use of immunohistochemistry, the NPCs were transfected 
with luciferin and GFP. This unique approach allowed the transfected cells and slices to be 
visualised upon  exposure to a luciferase substrate (a ‘luciferin penetration formula’), whilst 
the animals were injected with 30 mM AkaLumine-HCL peritoneally, and imaged using a two 
photon microscope as described in Chapter 2. In vivo deep tissue bioluminescent imaging was 
performed according to previously published methods (Iwano et al., 2018).  Bioluminescence 
was successfully detected in vitro (Fig.5.4A), in vivo (Fig.5.4C) and ex vivo (Fig.5.4B). GFP 
visualisation was also successful in aiding the accurate placement of recording and stimulating 
electrodes  in brain slices (Fig.5.4D-E). These data represent an important step in translating 
the work toward human studies, as deep tissue graft visualisation in vivo will be vital for 
minimally invasive evaluation of graft survival.  
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Figure 5.4: Bioluminescence and GFP transfection allow for graft visualisation in vitro, in vivo and 
ex vivo 
All cells were transfected (by Dr Ngoc-Nga Vinh) with a viral construct containing both GFP and 
luciferase (created by Dr Amit Jathoul) to allow visualisation of the graft multiple stages of 
development. Bioluminescence was observed in a two-photon imager.  
A: Bioluminescence in hWGE derived neuronal cells in vitro at DIV21 following exposure to D-
Lucierfin in a cell penetration formula as described in the methods chapter of this thesis.  
B: Bioluminescence in hWGE derived graft ex vivo, importantly only in one hemisphere in line with 
the grafting procedure.  
C: Bioluminescence in rWGE grafted lister hooded rat, showing clearly deep tissue two-photon 
bioluminescence in vivo, further highlighted with the white arrow.  
D: hESC grafted striatum in brightfield, with stimulating (right) and recording (left) electrodes. 
Braided silver wire was used to secure the slice for recordings. 
E: hESC grafted striatum showing GFP illumination, with stimulating (right) and recording (left) 
electrodes. Same slice as shown in D.  
Abbreviations: GFP: green fluorescent protein, hWGE: human whole ganglionic eminence, rWGE: 
rat whole ganglionic eminence, hESC: human embryonic stem cell 
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5.4.5 Functional integration of stem cell-derived graft within host striatum is minimal 
 To investigate the synaptic transmission between the graft and host, extracellular field 
potential recordings were performed in the engrafted animals. Extracellular field potentials 
were performed at various recording positions, as described in full in Chapter 2. Figure 5.1. 
and described briefly again below. Intrastriatal field potential recordings were taken in the 
hemispheres contralateral and ipsilateral to the stem cell derived grafts in order to establish 
baseline activity. The graft-host recordings were taken by placing the stimulating electrode in 
the graft and recording within the host, then swapped to achieve the host-graft recordings. 
The intragraft recordings were taken with both electrodes placed within the graft. The 
location of the graft was determined using the GFP as shown in Figure 5.4.  
rWGE engrafted animals. In the rWGE (yellow, Figure 5.5A) engrafted animals, the 
contralateral (-0.74 +/- 0.07 mV, n = 16) and ipsilateral (-0.67 +/- 0.14 mV, n = 16) intrastriatal 
recordings were not significantly different (p > 0.05). The graft-host (-0.07 +/- 0.02 mV, n = 
14), intragraft (-0.07 +/- 0.02 mV, n = 14) and host-graft (-0.07 +/- 0.02 mV, n = 14) recordings 
were also insignificantly different from each other (p > 0.05). The hashtag (#) i shows that 
both contralateral (p < 0.01, p < 0.01, p < 0.01, respectively) and ipsilateral (p < 0.01, p < 0.01, 
p < 0.01, respectively) intrastriatal peak amplitudes were significantly different from each of 
the three other recordings.  
hESC engrafted animals. In the hESC (green, Figure 5.5B) engrafted animals, the contralateral 
(-0.73 +/- 0.08 mV, n = 21) and ipsilateral (-1.31 +/- 0.34 mV, n = 21) intrastriatal recordings 
were shown to be significantly different (p < 0.01). The graft-host (-0.07 +/- 0.01 mV, n = 18), 
intragraft (-0.17 +/- 0.07 mV, n = 18) and host-graft (-0.09 +/- 0.02 mV, n = 18) recordings 
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were not significantly different from each other (p > 0.05). Not shown due to space 
constraints, post hoc Bonferoni corrected t-test analyses also revealed that the contralateral 
(p < 0.01, p < 0.01, p < 0.01 respectively) and ipsilateral (p < 0.01, p < 0.01, p < 0.01 
respectively) intrastriatal peak amplitudes were also significantly different from each in the 
three other recordings.  
hWGE engrafted animals. In the hWGE (purple, Figure 5.5C) engrafted animals the 
contralateral (-0.82 +/- 0.09 mV, n = 18) and ipsilateral (-0.79 +/- 0.08 mV, n = 18) intrastriatal 
recordings were not significantly different (p > 0.05). The graft-host (-0.11 +/- 0.01 mV, n = 
13), intragraft (-0.12 +/- 0.01 mV, n = 13) and host-graft (-0.11 +/- 0.03 mV, n = 13) recordings 
were not significantly different from each other (p > 0.05). The hashtag (#) indicates that both 
contralateral (p < 0.01, p < 0.01, p < 0.01, respectively) and ipsilateral (p < 0.01, p < 0.01, p < 
0.01, respectively) intrastriatal peak amplitudes were significantly different from each of the 
three other recordings.  
Shown in Figure 5.5, normal fEPSPs were seen contralaterally, in all experimental groups, 
whilst no synaptic transmission was seen between the graft and the ipsilateral host striatum. 
Importantly, normal fEPSPs were seen in the remaining striatum ipsilaterally. Interestingly, a 
small presynaptic response was occasionally seen intragraft.  
Taken together, these data suggest the slices are healthy and alive, as indicated by healthy 
fEPSPs contralaterally and in the remaining ipsilateral striatum. However, functional 
integration appears to be severely limited which implies either that the grafts do not survive 
to the time point at which recordings were taken (22 weeks post transplantation +/- 2 weeks) 
or that the grafts do not functionally integrate with the host striatum. 
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Figure 5.5: Little to no functional integration of graft and host striatum 
Extracellular field potential recordings were performed in coronal slices at various recording positions as 
described in full in  Chapter 2. Figure 1, to generate the fEPSP peak amplitude values shown here. 
A: Summary of the fEPSP peak amplitude values at various recordings positions in rWGE grafted striatum 
(yellow). The hashtag (#) is denoted to show that both contralateral and ipsilateral intrastriatal peak 
amplitudes were significantly different from each of the three other recordings (p < 0.01 each) 
B: Summary of the fEPSP peak amplitude values at various recordings positions in hESC grafted striatum 
(green). The contralateral and ipsilateral intrastriatal peak amplitudes were shown to be significantly 
different from each other (p < 0.05). The peak amplitudes of the other three recordings were shown to be 
statistically indifferent (p = 1) from eachother. The contralateral intrastriatal response was significantly 
different from each of the three recordings (p < 0.05, p < 0.05, p < 0.05 respectively, not shown due to 
space restrictions), as was the ipsilateral response (p < 0.01, p < 0.01, p < 0.01 respectively, also not shown).  
C: Summary of the fEPSP peak amplitude values at various recordings positions in hWGE grafted striatum 
(purple). The hashtag (#) is denoted to show that both contralateral and ipsilateral intrastriatal peak 
amplitudes were significantly different from each of the three other recordings (p < 0.01 each) 
D: The bottom right panel shows an exemplary trace from a rWGE host à graft recording. Visible is the 
stimulus artifact, but a lack of presynaptic afferent volley or post-synaptic field potential.  
Data shown throughout, except in the exemplary recording, as mean values +/- SEM. p* <0.05. n defined 
in text. 
Abbreviations: rWGE: rat whole ganglionic eminence hESC: human embryonic stem cells, hWGE: human 
whole ganglionic eminence, fEPSP: rat whole ganglionic eminence  
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5.4.6 Stem cell derived grafts restore ipsilateral intrastriatal synaptic communication  
To examine whether the grafts were able to produce a beneficial effect without functional 
integration, the healthy contralateral responses were grouped and then the ipsilateral 
intrastriatal responses from each of the groups (rWGE not shown) were plotted and analysed 
by ANOVA, Bonferroni post-hoc tests..  
In Figure 5.6A the mean input/output curves demonstrate that fEPSPs have smaller peak 
amplitudes intrastriatally in the ipsilateral lesioned hemisphere (red), than those of the 
grouped contralateral striatum; the group described as healthy (blue). The ipsilateral field 
potentials were completely restored in rWGE (yellow) and hWGE (purple) engrafted animals, 
and increased in hESC engrafted animals (green).  The peak amplitudes from each group were 
then plotted and compared (Figure 5.6C). The ipsilateral fEPSP peak amplitude in lesioned 
animals (-0.23 +/- 0.03 mV, n = 8) was significantly smaller than the grouped contralateral 
fEPSP peak amplitude, termed healthy, (-0.75 +/ 0.05 mV, n = 57, p < 0.05). The ipsilateral 
intrastriatal fEPSP peak amplitude in hWGE grafted animals (-0.79 +/- 0.08 mV, n = 18) was 
not significantly different from that seen in the healthy striatum (p > 0.05). The ipsilateral 
intrastriatal fEPSP peak amplitude in hESC engrafted animals (-1.31 +/- 0.34 mV, n = 21) was 
significantly higher than the ipsilateral response seen in hWGE grafted (p < 0.05), lesioned (p 
< 0.001) and healthy striatum (p < 0.05). The ipsilateral hWGE engrafted response was not 
significantly different from either the lesioned hemisphere (p > 0.05), the healthy (p > 0.05) 
or the rWGE engrafted striatum (p > 0.05), but smaller than the hESC engrafted striatum (p < 
0.05).   
Figure 5.6B shows the input/output curves when normalized to their respective maximal 
amplitude, revealing few differences.  Figure 5.6D then shows the half maximal value from 
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each group, taken as the stimulus intensity required to reach 50% maximal fEPSP peak 
amplitude. This can be seen as a rudimentary measure of how much stimulus is required to 
evoke a response. One-way ANOVA revealed no significant differences between the means 
of each group; Healthy (33.16 +/- 1.76 V, n = 57), Lesioned (30.07 +/- 15.31 V, n = 8), rWGE 
engrafted (30.61 +/- 3.22 V, n = 16), hWGE engrafted (29.94 +/- 5.56 V, n = 18) and hESC 
engrafted (19.95 +/-2.27 V, n = 21, p = 0.2012). 
 
Thus, the fEPSPs were restored in all stem cell engrafted hemispheres and, in the case of 
hESCs, improved significantly. This implies the graft does in fact have a beneficial effect on 
the health of the ipsilateral striatum despite a lack of functional integration by an as yet 
unknown mechanism.  
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Figure 5.6: Increased Ipsilateral Intrastriatal fEPSP Peak Amplitude in hESC grafted striatum 
Extracellular field potential recordings were performed in coronal slices at various recording positions as 
described in full in  Chapter 2. Figure 1, to generate the fEPSP peak amplitude, and input output curves shown 
here. Input/Output curves were generated by sequentially increasing the stimulus strength from 0 V to 80 V 
and recording the fEPSP peak amplitude at each intensity.  
A: Mean input output curves showing the response in the ipsilateral lesioned hemisphere (red), the grouped 
contralateral striatum termed healthy (blue), rWGE grafted hemispheres (yellow) hWGE grafted hemispheres 
(purple) and in hESC grafted animals (green).  
B: Mean input output curves, normalized to the maximal value from each group, showing the response in the 
ipsilateral lesioned hemisphere (red), the grouped contralateral striatum termed healthy (blue), rWGE grafted 
hemispheres (yellow) hWGE grafted hemispheres (purple) and in hESC grafted animals (green).  
C: Mean fEPSP peak amplitude from the ipsilateral lesioned hemisphere (red), the grouped contralateral 
striatum termed healthy (blue), rWGE grafted hemispheres (yellow) hWGE grafted hemispheres (purple) and 
in hESC grafted animals (green).  
D: Mean half maximal value from each group, taken as the stimulus intensity required to reach 50% maximal 
fEPSP peak amplitude. The ipsilateral lesioned hemisphere (red), the grouped contralateral striatum termed 
healthy (blue), rWGE grafted hemispheres (yellow) hWGE grafted hemispheres (purple) and in hESC grafted 
animals (green) are shown.  
Data shown throughout, except in the exemplary recording, as mean values +/- SEM. p* <0.05, p*** < 0.001. n 
defined in text. 
Abbreviations: hESC: human embryonic stem cell, hWGE: human whole ganglionic eminence, fEPSP: field 
excitatory post synaptic potential 
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5.5 Discussion & Conclusion 
 
5.5.1 Lack of functional integration 
Existing electrophysiological data to support functional stem cell derived graft-host striatum 
connections is limited, despite the wealth of literature surrounding foetal (McBride et al., 
2004; Ryu et al., 2004) and embryonic (Campbell et al., 1993; Döbrössy and Dunnett, 2006; 
Aubry et al., 2008; Ma et al., 2012; Reidling et al., 2018) grafts into HD animal models. Several 
studies have suggested functional integration, but few are based on electrophysiological 
studies. Through extensive use of immunohistochemical staining, Ma et al. suggested hESC 
derived grafts received both glutamatergic and dopaminergic inputs (Ma et al., 2012). Whilst 
a highly valid experimental approach, the presence of protein markers support the presence 
of synapses but cannot be seen as definitive proof of synaptic functionality.  Gaura et al., 
reported seeing increased cortical metabolism through the use of FDG-positron enhanced 
tomography in human subjects following bilateral foetal grafts (Gaura et al., 2004). Similarly, 
this cannot be taken as proof of functional electrochemical corticostriatal connectivity.  
One paper did examine the electrophysiological connectivity of foetal grafts in a lesion rodent 
model of Huntington’s Disease. In this paper, Mazzochi-Jones et al., reported bidirectional 
electrophysiological connectivity between the engrafted foetal cells and the lesioned host 
striatum (Mazzocchi-Jones et al., 2009). This finding is in direct contrast to the fidnings in this 
report; that there is no functional electrochemical connectivity. Mazzochi-Jones et al., used 
mice in their experiments compared to the experiments performed in rats shown here. 
Furthermore, a slightly different recording was performed as Mazzochi-Jones was 
investigating the coritco-striatal pathways, yet these differences combined are not expected 
make such a confounding difference. However, the timeline of the experiments and the age 
 O.G. Steele 
BIOSI PG 1757384  109 
of the animals is not clear, which could make a very large difference. It is clearly referenced 
that the animals were grafted 7 days post lesion surgery, yet the time between 
transplantation surgery and electrophysiological recordings is not specified. The graft-host 
electrophysiological recordings presented here were performed in 9 month old animals at 22 
weeks post transplantation. Perhaps the grafts simply didn’t survive as long as 22 weeks in 
vivo, making recordings of functional connections not only technically challenging but 
essentially impossible. 
This observation of poor graft survival is supported in the literature. Reidling et al., noted that 
at four weeks post transplantation graft survival had already dropped to 41 %, falling further 
to roughly 25 % six months post transplantation (Reidling et al., 2018), and could also be a 
contributing factor in this project.. The very low intragraft fEPSP peak amplitudes (Fig.4) and 
the poor level of spontaneous activity seen in hESC/hWGE cultures at DIV21 (Fig.3) further 
support the notion that the graft health may be low. However, that the rWGE derived MSNs 
produced fully spontaneous action potentials in vitro suggests these neurons at least had the 
potential to mature into fully functional MSNs in vivo. Furthermore, the presence of 
bioluminescent signals in vivo and ex vivo (Fig.3) suggest the grafts are indeed alive as the 
enzymatic reactions required to produce bioluminescence could not occur within dead cells. 
Therefore, it seems sensible to assume that engrafted material was alive at the time of the 
experimentation but suggest that they had differentiated poorly into functionally active 
neurons in vivo. Immunohistochemical studies on these slices could clarify whether the cells 
at least expressed the relevant markers of mature MSNs such as DARP32 and did not express 
markers of pluripotency, such as Oct-4 and Nanog. 
One previous study has reported whole-cell patch-clamp recordings of hESC-derived MSNs 
transplanted into a rodent HTT fragment model of HD, reporting spontaneous post-synaptic 
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currents (Reidling et al., 2018). Spontaneous post-synaptic currents being indicative of 
synaptic connections from other neurons being registered on grafted cells. However, it 
cannot be concluded definitively that this is communication with host neurons and not 
exclusively communication from other engrafted cells. This is indeed a problem that would 
have been faced had this project uncovered synaptic communication between the engrafted 
cells and the host. Despite the nature of recordings performed in this project (selectively 
stimulating in the graft and recording in the host, and vice versa) this would still not have 
been definitive. The best way to confirm definitively host-graft connectivity would 
incorporate the use of channel rhodopsins. If the engrafted cells were also transfected with a 
channel rhodopsin sensitive to blue light, subsequent exposure to blue light post 
transplantation and recording in the host striatum would definitively confirm whether the 
engrafted cells functionally innervate the host striatum as cells do not natively respond to 
blue light. Liske et al., recently utilised a single channel rhodopsin capable of stimulating and 
inhibiting neuronal firing (Liske et al., 2013), and would be suitable for use in future 
transplantation experiments. 
 
5.5.2 Beneficial effect of stem cell derived graft despite functional integration 
Numerous stem cell transplantation studies have described beneficial effects in behaviour 
and learning tests, both in animal models of HD (Campbell et al., 1993; McBride et al., 2004; 
Ryu et al., 2004; Döbrössy and Dunnett, 2006; Aubry et al., 2008; Reidling et al., 2018) and 
human HD patients (Bachoud-Lévi et al., 2000; Gaura et al., 2004; Reuter et al., 2008). Indeed, 
unpublished work, conducted by Dr Ana Garcia Aguirre, on these same animals prior to 
electrophysiological interrogation (not included in this thesis) support these claims by 
suggesting behavioural improvements in all of the grafted experimental groups. Thus, it 
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seems beyond doubt that stem cell derived grafts do indeed confer a beneficial effect in this 
animal model of HD. However the mechanism by which this occurs remains elusive.  
The first, and perhaps most logical hypothesis, is beneficial effect via electrophysiological 
integration. As discussed previously, there have been limited studies conclusively reporting 
electrophysiological integration of stem cell derived grafts. This is supported further by the 
findings presented in this thesis, suggesting that minimal to no functional integration (Fig.5.5). 
Therefore, it is unlikely the beneficial mechanism is via electrophysiological interrogation; 
however this cannot be disproved completely without future channel rhodopsin experiments. 
Interestingly, a benefit can be detected electrophysiologically as shown in this thesis via 
restoring ipsilateral intrastriatal field potentials (Fig.6). Reidling et al., also demonstrated an 
electrophysiological benefit by suggesting that the hyperexcitability of the host striatum was 
reduced when grafted with hESC derived grafts (Reidling et al., 2018). Direct comparisons are 
difficult to draw between the Reidling study and the work in this thesis due to the use of 
different animal models. Reidling et al., used the transgenic R6/2 fragment model of HD, 
whereby the animals express exon 1 of the human HD gene with an expanded CAG repeat 
first established by Mangiarini et al., (1996). Hyperexcitability has been demonstrated in 
these animals through a possible impairment of excitatory corticostriatal glutamatergic 
pathways (Cepeda et al., 2003) and GABAergic inhibitory pathways (Cummings et al., 2009). 
As the excitotoxic QA model of HD used in this thesis only damages the striatum and does not 
possess any mutant huntingtin, corticostriatal pathways were not considered. Experimentally 
it also proved impossible to interrogate the corticostriatal pathways due to the vastly 
extended age of these animals compared to other groups and the ongoing effects of synaptic 
pruning. Corticostriatal pathways undoubtedly still existed in these animals but the number 
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of the pathways would have decreased significantly over time making the likelihood of 
interrogation via extracellular field potential recordings close to impossible. 
Another potential theory could simply be through mechanical support, whereby the graft 
occupies the space that the cells have lost during model progression thus preventing the 
further collapse within the striatum. Whilst this is likely a contributing factor, it is unlikely the 
only factor due to the benefit being seen electrophysiologically in this thesis and by Reidling 
et al. The work conducted by Campbell et al., (Campbell et al., 1993) suggesting graft specific 
release of GABA as a result of host derived afferent activity, also do not support a solely 
mechanical hypothesis.  
A further hypothesis for the mechanism behind the beneficial effect of neural transplantation 
is via the release of neurotrophic factors, such as (BDNF). First isolated by Barde et al. (1982), 
BDNF has been shown to have roles in neuronal growth, survival and function (see reviews 
by Chao (2003) and Binder & Scharfman (2004) for details) as well as memory and learning. 
BDNF has been suggested to play roles in synapse formation through disruption of cadherin-
b-catenin complexes (Bamji et al., 2006) and axonal outgrowth (Blurton-Jones et al., 2009), 
processes thought to be central to learning and memory. Furthermore, hippocampus specific 
knock-down of BDNF significantly impairs cognitive function in a lentiviral Cre recombinase 
deletion of the BDNF gene in otherwise wild type adult mice (Heldt et al., 2007), suggestive 
of BDNF’s key role in cognition. As cognitive decline is also a feature of HD as it is of AD, the 
role of BDNF in HD must be further examined. HD patients often present with reduced levels 
of BDNF (Ferrer et al., 2000; Zuccato et al., 2001, 2011) likely as a consequence of decreased 
BDNF transcriptional activation (Zuccato et al., 2001) as well as transport from the cortex to 
the striatum (Gauthier et al., 2004). This reduction in BDNF is also mirrored in animal models 
of HD (Spires et al., 2004; Gharami et al., 2008), prompting therapies aimed at increasing 
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BDNF levels. In an AD animal model cognitive performance was fully restored following 
transplant of stem cells overexpressing BDNF (Wu et al., 2016). Interestingly, the 
overexpression of BDNF in this study was also suggested to aid functional integration with 
“existing neuronal networks”. In HD animal model studies, increased BDNF levels have also 
been seen in transplant therapies of stem cell derived grafts not overexpressing BDNF 
(Blurton-Jones et al., 2009; Reidling et al., 2018), with functional improvements seen in both 
cases. Recently, Zimmerman et al., took the step to combine BDNF therapy with neural cell 
replacement therapy by transplanting ESC-derived neural progenitor cells that have been 
programmed to overexpress BDNF resulting in restoration of motor function across three 
different animal models of HD. Taken together, the existing literature and the results 
presented in this thesis strongly support the hypothesis that the graft may have a beneficial 
effect through release of secretory vesicles and neurotrophic factors.  
 
5.5.3 QA lesioned model and combined therapies 
Direct comparisons between studies is difficult due, in part, to the range of different models 
of HD. In this study, the QA lesion rat model was used. The QA acid lesion HD model has been 
widely adopted due to the excitotoxicity of QA (Schwarcz and Köhler, 1983; Tavares et al., 
2000, 2002), damage to MSN populations (Schwarcz and Köhler, 1983) and mimicry of the 
classical HD phenotype (Beal et al., 1991). The increased levels of QA in early HD patients 
(Guidetti et al., 2004) lends further credibility to the use of QA lesions to model HD. However, 
the QA lesion model lacks perhaps the most common hallmark of HD; mutant huntingtin 
aggregates. For this reason the QA lesion model does not fully recapitulate HD. Therefore, 
the results from this study need to be considered within the constraints of the model itself. 
Shown here, stem cell-derived grafts can restore synaptic communication intrastriatally 
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following excitotoxic damage in the striatum, excitotoxic damage being one possible cause of 
the cell death seen in HD. To claim that stem-derived grafts can provide functional 
electrophysiological benefits in HD, the impact of mutant huntingtin aggregates in graft 
experiments on electrophysiological properties needs to be examined. The mutant huntingtin 
may damage the graft in the same way that the native cells are damaged, either preventing 
graft success at all or severely shortening lifespan. As described earlier, previous graft 
experiments conducted in HD models containing the genetic mutation for HD, and therefore 
the toxic aggregates, have included little electrophysiological interrogation. 
An alternative approach to HD therapy is to reduce the build-up of mutant huntingtin in the 
hope of preventing or slowing damage to the brain. Significant progress has been made in 
reducing the huntingtin aggregates, largely through the use of antisense oligonucleotide 
(ASO) therapy (Carroll et al., 2011; Kordasiewicz et al., 2012; Stanek et al., 2013; Østergaard 
et al., 2013; Evers et al., 2014; Skotte et al., 2014; Southwell et al., 2014; Rué et al., 2016). 
ASOs are short singular strands of ribonucleic acid (RNA) that facilitate the degradation of 
complementary target sequences of messenger RNA (mRNA) preventing the translation of 
mRNA into protein. ASO therapy has been shown in mice fragment models of HD to reduce 
huntingtin mRNA levels (Carroll et al., 2011; Kordasiewicz et al., 2012; Stanek et al., 2013; 
Østergaard et al., 2013; Evers et al., 2014; Skotte et al., 2014; Southwell et al., 2014; Rué et 
al., 2016) and subsequently improve both psychological parameters (Stanek et al., 2013) and 
motor function (Kordasiewicz et al., 2012; Stanek et al., 2013; Rué et al., 2016). These studies 
have culminated in a recent phase three clinical trial that reported success in reducing 
circulated CSF huntingtin levels in a dose dependant manner (Tabrizi et al., 2018), 
subsequently gaining significant media attention (Devlin, 2017; Gallagher, 2017; New 
Scientist, 2017).  
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Whilst a promising step towards an effective therapy for HD patients, the therapy would only 
be effective at preventing damage either taking place or progressing. ASO therapy would not 
be able to reverse disease progression and treat the underlying cell loss, for this a cell 
replacement therapy will be required. A more long-term solution may be to utilise a cell 
replacement therapy to treat the cell loss in conjunction with an ASO therapy to reduce 
mutant huntingtin levels, in turn enhancing the lifespan of the graft and the overall benefit to 
the patient. Using stem cell-derived grafts appears a promising avenue for the cell 
replacement but is associated with a host of ethical problems related to the source of the 
stem cells and practical issues such as the possibility of immune rejection. Using patient 
derived stem cells and autografting them could alleviate the immune rejection possibility and 
a lot of the ethical concerns surrounding embryonic stem cells.  Using the patient’s own stem 
cells does present two further problems; 1) the patient has a limited source of adult stem cells 
and 2) these stem cells will still contain the mutation giving rise to HD in the first place.  
Clustered repeated interspersed palindromic repeats and associated systems (CRISPR/Cas9) 
have the ability to edit the genome at any desired sequence and have recently been used to 
correct the HD mutation (Shin et al., 2016) in patient fibroblasts. The versatility of 
CRISPR/Cas9 is highlighted further by Black et al., who managed the direct conversion of 
human fibroblasts into neuronal cells (Black et al., 2016). Utilising these two methods could 
allow for the generation of HD corrected neuronal cells from patient fibroblasts, therefore 
providing a near limitless source of iPS cells that have few ethical issues associated with them 
and have little to no risk of immune rejection following transplantation. Combining this 
hypothetical CRISPR/Cas9 based cell replacement therapy with the promising ASO huntingtin 
lowering techniques may finally be a step toward a long lasting and effective therapy for HD.  
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Chapter 6 – General discussion and concluding remarks 
 
6.1 MATLAB based analysis for large complex datasets 
The use of MATLAB has been invaluable in analysing the large complex datasets associated 
with neurophysiological experiments. Not only has MATLAB expedited the whole procedure 
of analysis, but it has made the process documented and repeatable. Methodology sections 
of published papers and articles are lengthy and meticulously detailed. However,  they rarely 
fully explain how the data were actually analysed. Commonly, researchers world-wide will 
have Excel spreadsheets that manipulate the data in numerous ways which are rarely 
described in the Methods section. In the interest of academic honesty and integrity it is highly 
recommended that the precise mechanics of the data analysis and interpretation are made 
transparent. Doing so will also enable academics at other institutions to analyse data in the 
exact same way and increase the comparability of the results. As discussed in Chapter 3, 
MATLAB can be intimidating to those who have not used the tool before-hand. However, 
every effort has been made to make learning the language more user friendly. The benefits 
of doing so cannot be stressed enough. However, it is important to note that many other 
programming languages exist, such as Python, C++ and Java each of which has their own 
respective merits.   
 
6.2 Stem cells in disease modelling and therapy 
Stem cells have the captivating ability to turn into any type of cell within the human body, 
thus their enormous potential for disease modelling and therapy. There are large ethical 
concerns associated with embryonic stem cells, whereas induced pluripotent stem cells 
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demand technical prowess. Stem cells have been used throughout both arms of this project 
successfully to not only model a ‘difficult to model’ neurological disease, CDKL5 deficiency, 
but also to provide therapeutic benefit in a neurodegenerative disease associated with vast 
amounts of cell loss. It is for these reasons that the positives significantly outweigh the 
negatives associated with stem cell research and therapy, and stem cells will likely continue 
to be used in both for decades to come to great effect. The advent of CRISPR/Cas9 based 
genetic engineering and the rapid advancements in genetic medicine have the potential 
revolutionise medicine, but not without the help of stem cell technologies in testing of the 
techniques.  
 
6.3 Electrophysiology in neurological disease research 
Underpinning all of the work conducted in this thesis is electrophysiology. Electrophysiology 
remains the best way of interrogating the functional properties of neurons. As invaluable as 
techniques such as immunohistochemistry and molecular biological approaches are, 
electrophysiology remains the only way to determine whether the cell is electrochemically 
active. Immunohistochemistry can tell you that a cell has the right markers to be active, and 
high-powered microscopy can tell you whether the cells morphology would be conducive to 
electrical activity - yet only electrophysiology can explicitly define whether a cell is 
electrochemically active and how. The ideal project would utilise electrophysiology in 
conjunction with other techniques such as immunohistochemistry, microscopy and calcium 
imaging to answer strictly defined questions in a multi-disciplinary and comprehensive 
manner. 
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